<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78203</article-id><article-id pub-id-type="doi">10.7554/eLife.78203</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Aberrant cortical development is driven by impaired cell cycle and translational control in a <italic>DDX3X</italic> syndrome model</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-272111"><name><surname>Hoye</surname><given-names>Mariah L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3430-2782</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272112"><name><surname>Calviello</surname><given-names>Lorenzo</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-272113"><name><surname>Poff</surname><given-names>Abigail J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6267-4201</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-272114"><name><surname>Ejimogu</surname><given-names>Nna-Emeka</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-272115"><name><surname>Newman</surname><given-names>Carly R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-280485"><name><surname>Montgomery</surname><given-names>Maya D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-272116"><name><surname>Ou</surname><given-names>Jianhong</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-35108"><name><surname>Floor</surname><given-names>Stephen N</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9965-9694</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-22683"><name><surname>Silver</surname><given-names>Debra L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9189-844X</contrib-id><email>debra.silver@duke.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03njmea73</institution-id><institution>Department of Molecular Genetics and Microbiology, Duke University Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Durham</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/029gmnc79</institution-id><institution>Centre for Functional Genomics, Human Technopole</institution></institution-wrap><addr-line><named-content content-type="city">Milan</named-content></addr-line><country>Italy</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/029gmnc79</institution-id><institution>Centre for Computational Biology, Human Technopole</institution></institution-wrap><addr-line><named-content content-type="city">Milan</named-content></addr-line><country>Italy</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03njmea73</institution-id><institution>Department of Cell Biology, Duke University Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Durham</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03njmea73</institution-id><institution>Duke Regeneration Center, Duke University Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Durham</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05yndxy10</institution-id><institution>Department of Cell and Tissue Biology, UCSF</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/032h4fk17</institution-id><institution>Helen Diller Family Comprehensive Cancer Center</institution></institution-wrap><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03njmea73</institution-id><institution>Department of Neurobiology, Duke University Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Durham</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03njmea73</institution-id><institution>Duke Institute for Brain Sciences, Duke University Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Durham</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Gleeson</surname><given-names>Joseph G</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0420db125</institution-id><institution>Howard Hughes Medical Institute, The Rockefeller University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05dxps055</institution-id><institution>California Institute of Technology</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>28</day><month>06</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e78203</elocation-id><history><date date-type="received" iso-8601-date="2022-02-26"><day>26</day><month>02</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-05-25"><day>25</day><month>05</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-02-21"><day>21</day><month>02</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.02.21.481343"/></event></pub-history><permissions><copyright-statement>© 2022, Hoye et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Hoye et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78203-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-78203-figures-v1.pdf"/><abstract><p>Mutations in the RNA helicase, <italic>DDX3X</italic>, are a leading cause of Intellectual Disability and present as <italic>DDX3X</italic> syndrome, a neurodevelopmental disorder associated with cortical malformations and autism. Yet, the cellular and molecular mechanisms by which DDX3X controls cortical development are largely unknown. Here, using a mouse model of <italic>Ddx3x</italic> loss-of-function we demonstrate that DDX3X directs translational and cell cycle control of neural progenitors, which underlies precise corticogenesis. First, we show brain development is sensitive to <italic>Ddx3x</italic> dosage; complete <italic>Ddx3x</italic> loss from neural progenitors causes microcephaly in females, whereas hemizygous males and heterozygous females show reduced neurogenesis without marked microcephaly. In addition, <italic>Ddx3x</italic> loss is sexually dimorphic, as its paralog, <italic>Ddx3y</italic>, compensates for <italic>Ddx3x</italic> in the developing male neocortex. Using live imaging of progenitors, we show that DDX3X promotes neuronal generation by regulating both cell cycle duration and neurogenic divisions. Finally, we use ribosome profiling <italic>in vivo</italic> to discover the repertoire of translated transcripts in neural progenitors, including those which are DDX3X-dependent and essential for neurogenesis. Our study reveals invaluable new insights into the etiology of <italic>DDX3X</italic> syndrome, implicating dysregulated progenitor cell cycle dynamics and translation as pathogenic mechanisms.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>During development, a complex network of genes ensures that the brain develops in the right way. In particular, they control how special ‘progenitor’ cells multiply and mature to form neurons during a process known as neurogenesis. Genetic mutations that interfere with neurogenesis can lead to disability and defects such as microcephaly, where children are born with abnormally small brains.</p><p><italic>DDX3X</italic> syndrome is a recently identified condition characterised by intellectual disability, delayed acquisition of movement and language skills, low muscle tone and, frequently, a diagnosis of autism spectrum disorder. It emerges when certain mutations are present in the <italic>DDX3X</italic> gene, which helps to control the process by which proteins are built in a cell (also known as translation). The syndrome affects girls more often than boys, potentially because <italic>DDX3X</italic> is carried on the X chromosome. Many of the disease-causing mutations in the <italic>DDX3X</italic> gene also reduce the levels of DDX3X protein. However, exactly what genes <italic>DDX3X</italic> controls and how its loss impairs brain development remain poorly understood. To address this problem, Hoye et al. set out to investigate the role of <italic>Ddx3x</italic> in mice neurogenesis.</p><p>Experiments with genetically altered mice confirmed that complete loss of the gene indeed caused severe reduction in brain size at birth; just as in humans with mild microcephaly, this was only present in affected females. Further genetic studies revealed the reason for this: the closely related <italic>Ddx3y</italic> gene, which is only present on the Y (male) chromosome, helped to compensate for the loss of <italic>Ddx3x </italic>in the male mice.</p><p>Next, the effect of the loss of just one copy of <italic>Ddx3x</italic> on neurogenesis was examined by following how progenitor cells developed. This likely reflects DDX3X levels in patients with the syndrome. Loss of the gene made the cells divide more slowly and produce fewer mature nerve cells, suggesting that smaller brain size and brain malformations caused by mutations in <italic>DDX3X</italic> could be due to impaired neurogenesis. Finally, a set of further biochemical and genetic experiments revealed a key set of genes that are under the control of the DDX3X protein.</p><p>These results shed new light on how a molecular actor which helps to control translation is a key part of normal brain development. This understanding could one day help improve clinical management or treatments for <italic>DDX3X</italic> syndrome and related neurological disorders.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>cortical development</kwd><kwd>DDX3X syndrome</kwd><kwd>neurogenesis</kwd><kwd>RNA helicase</kwd><kwd>translation</kwd><kwd>radial glia</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R21HD104514</award-id><principal-award-recipient><name><surname>Silver</surname><given-names>Debra L</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01NS120667</award-id><principal-award-recipient><name><surname>Floor</surname><given-names>Stephen N</given-names></name><name><surname>Silver</surname><given-names>Debra L</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>F32NS112566</award-id><principal-award-recipient><name><surname>Hoye</surname><given-names>Mariah L</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>DP2GM132932</award-id><principal-award-recipient><name><surname>Floor</surname><given-names>Stephen N</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000875</institution-id><institution>Pew Charitable Trusts</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Floor</surname><given-names>Stephen N</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>Holland-Trice Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Silver</surname><given-names>Debra L</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>DDX3X Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Floor</surname><given-names>Stephen N</given-names></name><name><surname>Silver</surname><given-names>Debra L</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution>Regeneration Next Initiative</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Hoye</surname><given-names>Mariah L</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The RNA helicase DDX3X controls neural progenitor division, cell fate, and translation during embryonic brain development.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The cerebral cortex is critical for higher order cognitive, motor, and sensory functioning. These processes rely upon embryonic development, when the proper number and types of neurons are generated (<xref ref-type="bibr" rid="bib35">Kriegstein and Alvarez-Buylla, 2009</xref>; <xref ref-type="bibr" rid="bib42">Lodato and Arlotta, 2015</xref>; <xref ref-type="bibr" rid="bib58">Silver et al., 2019</xref> ). At the onset of cortical development, neuroepithelial cells divide symmetrically to expand the progenitor pool before transitioning into radial glial cells (RGCs). In the ventricular zone (VZ), RGCs undergo symmetric self-renewing divisions or asymmetric divisions to produce either intermediate progenitors (IPs) or neurons. IPs, also referred to as basal progenitors, divide 1–2 times in the sub-ventricular zone (SVZ) before terminally differentiating into neurons. While mouse neurogenesis largely relies on RGCs and IPs, humans have a more expansive neurogenic basal progenitor population. Excitatory neurons are produced in an inside-out fashion; wherein deep layers (V/VI) are the earliest born, followed by production of superficial neurons (IV-II/III). Newborn neurons migrate to the cortical plate (CP) where they differentially project axons depending on their laminar position. Impairments in these steps of cortical development can cause neurodevelopmental disorders, including microcephaly, intellectual disability (ID), and autism spectrum disorder (ASD) (<xref ref-type="bibr" rid="bib52">Polioudakis et al., 2019</xref>; <xref ref-type="bibr" rid="bib70">Willsey et al., 2013</xref>; <xref ref-type="bibr" rid="bib71">Willsey et al., 2021</xref>).</p><p><italic>De novo</italic> mutations in the RNA helicase, <italic>DDX3X</italic>, are one of the leading causes of ID in females and underlie <italic>DDX3X</italic> syndrome (<xref ref-type="bibr" rid="bib3">Beal et al., 2019</xref>; <xref ref-type="bibr" rid="bib39">Lennox et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Scala et al., 2019</xref>; <xref ref-type="bibr" rid="bib59">Snijders Blok et al., 2015</xref>; <xref ref-type="bibr" rid="bib69">Wang et al., 2018</xref>). <italic>DDX3X</italic> is X-linked, which likely explains the preponderance of female cases; although an increasing number of <italic>de novo</italic> and inherited <italic>DDX3X</italic> mutations are found in males (<xref ref-type="bibr" rid="bib32">Kellaris et al., 2018</xref>; <xref ref-type="bibr" rid="bib47">Nicola et al., 2019</xref>). While <italic>DDX3X</italic> syndrome is characterized by ID, these individuals also commonly present with muscle tone and gait abnormalities, language deficits, abnormal brain MRIs (particularly white matter loss and corpus callosum defects), and many are diagnosed with ASD (<xref ref-type="bibr" rid="bib27">Johnson-Kerner et al., 1993</xref>; <xref ref-type="bibr" rid="bib39">Lennox et al., 2020</xref>; <xref ref-type="bibr" rid="bib63">Tang et al., 2021</xref>). Indeed, <italic>DDX3X</italic> mutations have been identified in ASD cohorts, and <italic>DDX3X</italic> is considered a high-confidence Autism gene (<xref ref-type="bibr" rid="bib24">Iossifov et al., 2014</xref>; <xref ref-type="bibr" rid="bib56">Ruzzo et al., 2019</xref>; <xref ref-type="bibr" rid="bib62">Takata et al., 2018</xref>; <xref ref-type="bibr" rid="bib75">Yuen, 2017</xref>). <italic>DDX3X</italic> mutations have also been linked to cancer progression, including medulloblastoma (<xref ref-type="bibr" rid="bib29">Jones, 2012</xref>; <xref ref-type="bibr" rid="bib53">Pugh, 2012</xref>; <xref ref-type="bibr" rid="bib55">Robinson et al., 2012</xref>), many of which overlap with ID-associated mutations. This oncogenic role is consistent with conserved functions of DDX3X in cell cycle progression (<xref ref-type="bibr" rid="bib10">Chen et al., 2016a</xref>; <xref ref-type="bibr" rid="bib33">Kotov et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">Li et al., 2014</xref>; <xref ref-type="bibr" rid="bib77">Zhang and Li, 2021</xref>). Notably, cell cycle duration is also strongly implicated in cortical development (<xref ref-type="bibr" rid="bib1">Arai et al., 2011</xref>; <xref ref-type="bibr" rid="bib36">Lange et al., 2009</xref>; <xref ref-type="bibr" rid="bib51">Pilaz et al., 2016</xref>; <xref ref-type="bibr" rid="bib50">Pilaz et al., 2009</xref>). Altogether, these clinical findings argue that <italic>DDX3X</italic> mutations are deleterious and suggest that cell cycle defects may underlie their association with cancer and ID.</p><p>Remarkably, over 100 <italic>de novo</italic> mutations have been identified in <italic>DDX3X</italic> syndrome, equally composed of nonsense/frameshift and missense (<xref ref-type="bibr" rid="bib27">Johnson-Kerner et al., 1993</xref>). The former class likely results in <italic>DDX3X</italic> haploinsufficiency and/or hypomorphic loss-of-function (LoF) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Consistent with this, in female mice, <italic>Ddx3x</italic> germline haploinsufficiency impairs postnatal brain architecture and causes behavioral deficits phenocopying aspects of human <italic>DDX3X</italic> syndrome (<xref ref-type="bibr" rid="bib5">Boitnott et al., 2021</xref>). In addition, using transient CRISPR approaches we previously showed that acute <italic>Ddx3x</italic> depletion in a subset of cells perturbed progenitor and neuron number (<xref ref-type="bibr" rid="bib39">Lennox et al., 2020</xref>). While these studies highlight the requirement of <italic>Ddx3x</italic> for cortical development, how it controls neurogenesis at the cellular and molecular level is unclear (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Indeed, the temporal and spatial requirements for DDX3X during cortical development are unknown, as are the dosage and sex-specific requirements.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Conditional knockout of <italic>Ddx3x</italic> in neural progenitors using <italic>Emx1</italic>-Cre leads to microcephaly in female mice.</title><p>(<bold>A</bold>) Schematic of DDX3X protein with human missense and nonsense mutations noted, along with helicase/RNA binding domains (red, blue). Nonsense mutations, highlighted in yellow, are predicted to act in a LoF manner. (<bold>B</bold>) (Left) DDX3X protein bound to an mRNA undergoing translation. (Right) Mouse embryo and corticogenesis showing neuroepithelial cells (light green), radial glial cells (RGCs, orange), intermediate progenitors (IPs, light blue), and neurons (multi-colored); <xref ref-type="fig" rid="fig1">Figure 1B</xref> adapted from Figure 1A and B from <xref ref-type="bibr" rid="bib22">Hoye and Silver, 2021</xref>. This study asks how does <italic>Ddx3x</italic> LoF impair mouse embryonic cortical development at a cellular and molecular level? (<bold>C</bold>) Representative sections of smFISH for <italic>Ddx3x</italic> in control, cHet female, and cKO male and female E12.5 cortices. (<bold>D</bold>) Quantification of <italic>Ddx3x</italic> smFISH signal in respective genotypes at E12.5. n=2–3 embryos/condition (<bold>E, F</bold>) Validation of <italic>Ddx3x</italic> mRNA knockdown in Tdtomato + cells from female (<bold>F</bold>) (control, cHet, cKO) and male (<bold>M</bold>) (control, cKO) brains sorted via FACS at E11.5 (<bold>E</bold>) and E14.5 (<bold>F</bold>). n=3–7 embryos/condition. (<bold>G</bold>) Quantification of <italic>Ddx3x</italic> levels in Tdtomato + cells from control female and male brains. n=8–10 embryos/condition. (<bold>H</bold>) Representative whole mount images of control, cHet female, and cKO male and female brains at P0. (<bold>I</bold>) Quantification of cortical area at P0. n=5–12 embryos/condition. (<bold>J</bold>) Representative sections of E14.5 brains stained with Sox2 (green), CC3 (magenta) and Hoechst (blue) showing low-magnification on left panel, and high magnification on 4 panels to the right. (<bold>K</bold>) Quantification of CC3 + cells in E14.5 control and cKO female cortices. n=4–5 embryos/condition. Scale bars, indicated. Error bars, S.D. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001. One-way ANOVA with Tukey’s (<bold>D, E, F, I</bold>), Student’s unpaired, two-tailed t-test (<bold>G, K</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78203-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title><italic>Ddx3x</italic> loss from neural progenitors, but not neurons leads to microcephaly and apoptosis.</title><p>(<bold>A</bold>) Representative western blot of indicated genotypes probed for DDX3X (top) and β-actin loading control (bottom). Densitometric quantification of bands is shown below each lane. These data also indicate this antibody is specific to DDX3X and does not cross react with DDX3Y. n=2–4 embryos/condition. (<bold>B</bold>) Temporal quantification of cortical area in control, cHet F, and cKO F at E14.5, E16.5 and P0. n=3–12 embryos/condition. (<bold>C</bold>) Quantification of CC3 + cells in control and cKO F at E12.5. n=4 embryos/condition. (<bold>D</bold>) Representative coronal sections from control, cHet F, and cKO F at E12.5 immunostained with CC3 (magenta) and Hoechst. (<bold>E</bold>) Representative coronal sections from control and cKO F at E12.5 immunostained with CC3 (green), Tuj1 (red) and Hoechst. (<bold>F</bold>) Representative coronal sections of smiFISH for <italic>Ddx3x</italic> mRNA in <italic>Nex</italic>-Cre control and cKO female cortices at P0 showing the ventricular zone (VZ) and cortical plate (CP). (<bold>G</bold>) Representative whole mount images of <italic>Nex</italic>-Cre control and cKO male and female brains at P0. (<bold>H</bold>) Quantification of <italic>Nex</italic>-Cre cortical area at P0. n=2–9 embryos/condition. (<bold>I</bold>) Representative coronal sections from <italic>Nex</italic>-Cre control and cKO F at P0 immunostained with CC3 (green), L1 (magenta) and Hoechst. One-way ANOVA with Tukey’s (<bold>B, H</bold>), Student’s unpaired, two-tailed t-test (<bold>C</bold>).</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Western blot anlaysis of DDX3X in embryonic brain samples.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78203-fig1-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78203-fig1-figsupp1-v1.tif"/></fig></fig-group><p>DDX3X is a cytoplasmic RNA helicase that promotes translation of mRNAs with highly structured 5′ UTRs (<xref ref-type="bibr" rid="bib9">Calviello et al., 2021</xref>; <xref ref-type="bibr" rid="bib48">Oh et al., 2016</xref>). Thus, an intriguing possibility is that DDX3X controls cortical development by regulating translation. Although DDX3X translational targets have been characterized in immortalized cells (<xref ref-type="bibr" rid="bib9">Calviello et al., 2021</xref>; <xref ref-type="bibr" rid="bib48">Oh et al., 2016</xref>), they have not been identified in the developing brain <italic>in vivo</italic>. This hinders an understanding of how DDX3X molecularly controls brain development. Further, while translational control is essential for corticogenesis (<xref ref-type="bibr" rid="bib4">Blair et al., 2017</xref>; <xref ref-type="bibr" rid="bib22">Hoye and Silver, 2021</xref>; <xref ref-type="bibr" rid="bib34">Kraushar et al., 2014</xref>; <xref ref-type="bibr" rid="bib74">Yang et al., 2014</xref>; <xref ref-type="bibr" rid="bib76">Zahr et al., 2018</xref>), there is limited genome-wide assessment of translation in the developing cortex, which restricts our understanding of this important layer of post-transcriptional regulation.</p><p>In this study, we use mouse genetics, live imaging of neural progenitors, and ribosome profiling to discover new underlying cellular and molecular mechanisms by which <italic>Ddx3x</italic> controls cortical development. Our study further reveals essential roles for translational regulation in directing cell fate decisions of the developing brain.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Conditional knockout of <italic>Ddx3x</italic> in neural progenitors causes microcephaly and profound apoptosis</title><p>To understand how <italic>Ddx3x</italic> LoF impairs cortical development <italic>in vivo</italic>, we employed a previously generated floxed <italic>Ddx3x</italic> mouse (<xref ref-type="bibr" rid="bib10">Chen et al., 2016a</xref>) and crossed it to <italic>Emx1</italic>-Cre (<xref ref-type="bibr" rid="bib18">Gorski et al., 2002</xref>). This strategy removes <italic>Ddx3x</italic> from neural progenitors beginning at E9.5, as well as their progeny. As <italic>Ddx3x</italic> is X-linked, we generated <italic>Emx1</italic>-Cre conditional knockout (cKO) females (<italic>Ddx3x<sup>lox/lox</sup></italic>) and males (<italic>Ddx3x<sup>lox/Y</sup></italic>) and conditional heterozygous (cHet) females (<italic>Ddx3x<sup>lox/+</sup></italic>). To verify <italic>Ddx3x</italic> mRNA levels were reduced, we performed single molecule inexpensive fluorescence <italic>in situ</italic> hybridization (smiFISH) (<xref ref-type="bibr" rid="bib65">Tsanov et al., 2016</xref>) at E12.5 (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). There were less <italic>Ddx3x</italic> mRNA puncta in cHet females than in controls and significantly less <italic>Ddx3x</italic> mRNA puncta in cKO males and females (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), demonstrating that <italic>Ddx3x</italic> levels are reduced.</p><p>We then quantitatively assessed <italic>Ddx3x</italic> levels in male and female embryonic brains. Towards this, we used the Cre reporter, <italic>Rosa26<sup>Ai14</sup></italic>, along with FACS to isolate TdTomato + cells from embryos, followed by RT-qPCR for <italic>Ddx3x</italic>. At E11.5, <italic>Ddx3x</italic> mRNA levels were ~30% reduced in cHet females,~40% reduced in cKO males and ~70% reduced in cKO females relative to their respective sex-matched controls (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). At E14.5, we quantified a similar degree of reduction of <italic>Ddx3x</italic> in mutant brains (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). The incomplete reduction of <italic>Ddx3x</italic> in females could reflect inefficiencies in recombination or preferential loss of mutant cells. Notably, control females expressed ~25% higher levels of <italic>Ddx3x</italic> than control males (<xref ref-type="fig" rid="fig1">Figure 1G</xref>), which was similarly evident in the quantification of smFISH data. We also quantified DDX3X protein levels using western blot analysis of E14.5 cortices (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). DDX3X protein levels were higher in control females compared to males, similar to that seen at the RNA level. Further, compared to controls, cHet females showed decreased DDX3X expression, and cKO males showed a striking reduction. These results further validate the <italic>Ddx3x</italic> cKO model, and are consistent with previous validation of this mouse (<xref ref-type="bibr" rid="bib10">Chen et al., 2016a</xref>).</p><p>The significant difference in <italic>Ddx3x</italic> levels between control females and males is consistent with previous findings in mice and humans (<xref ref-type="bibr" rid="bib66">Tukiainen, 2017</xref>; <xref ref-type="bibr" rid="bib73">Wu et al., 2014</xref>) and suggests <italic>Ddx3x</italic> partially escapes X chromosome inactivation (XCI) in the embryonic cortex. Altogether, the qPCR, smFISH and western analyses demonstrate divergent <italic>Ddx3x</italic> levels in males and females in the developing brain. Further, these results validate and establish <italic>Emx1</italic>-Cre; <italic>Ddx3x</italic> conditional mice as a model to interrogate dose-dependent and sex-specific requirements of <italic>Ddx3x</italic> throughout cortical neurogenesis.</p><p>We next assessed gross cortical anatomy and size in <italic>Ddx3x</italic> mutant embryos. Strikingly, homozygous loss of <italic>Ddx3x</italic> from neural progenitors and their progeny led to profound microcephaly in cKO females at postnatal day 0 (P0) (<xref ref-type="fig" rid="fig1">Figure 1H, I</xref>). The decrease in cortical area began at E14.5, and by P0 was reduced by 50% (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). In contrast, no significant reduction in cortical area was observed in cHet females or cKO males (<xref ref-type="fig" rid="fig1">Figure 1H, I</xref>). These data demonstrate that the developing brain requires <italic>Ddx3x</italic>.</p><p>As microcephaly is often associated with massive cell death, we assessed apoptosis in <italic>Ddx3x</italic> cKO females by immunostaining E12.5 and E14.5 sections for the apoptotic marker, cleaved caspase-3 (CC3). We observed ~5% of cells in cKO females were CC3+ at E12.5 and ~15% were CC3+ at E14.5 (<xref ref-type="fig" rid="fig1">Figure 1J and K</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C, D</xref>). Apoptotic cells were both Tuj1+ and Tuj1-, suggesting complete <italic>Ddx3x</italic> loss causes death of both progenitors and newborn neurons (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). In contrast, and consistent with the absence of microcephaly in cHet females and cKO males, CC3 + cells were not detected at either E12.5 or E14.5 in these genotypes (<xref ref-type="fig" rid="fig1">Figure 1J</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). Altogether, these data suggest widespread apoptosis is likely a substantial contributor to the reduced cortical area in cKO female mice.</p><p>The extensive apoptosis in cKO females could be due to <italic>Ddx3x</italic> requirements in neural precursors, or alternatively independent requirements in newborn neurons. To understand how <italic>Ddx3x</italic> loss impacts neuronal survival, we used <italic>Neurod6</italic>-Cre (herein referred to by alias, <italic>Nex</italic>-Cre), which is active in post-mitotic excitatory neurons beginning at E12.5, to generate <italic>Nex</italic>-Cre, cKO females (<italic>Nex</italic>-Cre;<italic>Ddx3x<sup>lox/lox</sup></italic>) (<xref ref-type="bibr" rid="bib17">Goebbels et al., 2006</xref>). <italic>Ddx3x</italic> depletion was validated using smFISH, which showed specific reduction in the cortical plate where neurons reside (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>). Unlike <italic>Emx1</italic>-Cre cKO females, we did not observe microcephaly or apoptosis in <italic>Nex</italic>-Cre, cKO females across cortical development (E13.5, E15.5, E17.5 (not shown) and P0; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G-I</xref>). This suggests that apoptosis of newborn neurons in the <italic>Emx1</italic>-Cre model is due to defects in neural precursors. Taken together, these data reinforce the significant role of <italic>Ddx3x</italic> in neural progenitors.</p></sec><sec id="s2-2"><title><italic>Ddx3x</italic> loss is sexually dimorphic and DDX3Y can compensate for loss of DDX3X</title><p>While the vast majority of individuals with <italic>DDX3X</italic> syndrome are females, males can harbor either maternally inherited or <italic>de novo DDX3X</italic> mutations (<xref ref-type="bibr" rid="bib32">Kellaris et al., 2018</xref>; <xref ref-type="bibr" rid="bib47">Nicola et al., 2019</xref>). Thus, as males only have a single copy of <italic>Ddx3x,</italic> we predicted that loss of <italic>Ddx3x</italic> in males would phenocopy cKO females. Surprisingly, cKO males did not display profound microcephaly or apoptosis (<xref ref-type="fig" rid="fig1">Figure 1H–K</xref>). Notably, males have a <italic>Ddx3x</italic> paralog, <italic>Ddx3y</italic>, on the Y chromosome which can compensate for <italic>Ddx3x</italic> at the translational level in immortalized cells (<xref ref-type="bibr" rid="bib67">Venkataramanan et al., 2021</xref>). Thus, we postulated that <italic>Ddx3y</italic> may offset the loss of <italic>Ddx3x</italic> in the neocortex. We first examined if <italic>Ddx3y</italic> levels were altered following <italic>Ddx3x</italic> reduction. In E11.5 <italic>Ddx3x</italic> cKO male cortices, <italic>Ddx3y</italic> mRNA levels were significantly elevated 1.4 fold on average (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). This suggests there is a transcriptional adaptation of <italic>Ddx3y</italic> in response to reduced <italic>Ddx3x</italic> in the embryonic cortex, consistent with findings in <italic>Ddx3x</italic> cKO hindbrains (<xref ref-type="bibr" rid="bib49">Patmore et al., 2020</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title><italic>Ddx3x</italic> knockout is sexually dimorphic and <italic>Ddx3y</italic> phenocopies <italic>Ddx3x</italic> loss.</title><p>(<bold>A</bold>) RT-qPCR quantification of <italic>Ddx3x</italic> and <italic>Ddx3y</italic> mRNA levels in FACS-isolated Tdtomato + cells from cKO male E11.5 cortices. n=5–8 embryos/condition. (<bold>B</bold>) Schematic of <italic>Ddx3y</italic> CRISPR sgRNA electroporation of E14.5 brain. (<bold>C</bold>) RT-qPCR quantification of <italic>Ddx3y</italic> and <italic>Ddx3x</italic> levels in GFP +FACS-isolated cells from E17.5 male and female mice electroporated with pCAG-GFP and either no sgRNA or <italic>Ddx3y</italic> sgRNA. n=2–5 embryos/condition. (<bold>D</bold>) Representative sections of E17.5 male brains electroporated at E14.5 with pCAG-GFP and either no sgRNA or <italic>Ddx3y</italic> sgRNA and stained with anti-GFP (grey). Dotted lines, ventricular and pial surfaces; brackets delineate equivalently sized bins. (<bold>E</bold>) Quantification of distribution of GFP + cells. n=3–5 embryos/condition. (<bold>F</bold>) Same as (<bold>D</bold>), but sections were stained with anti-GFP (grey), Sox2 (magenta), and Neurod2 (green). (<bold>G, H</bold>) Quantification of GFP co-localization with Sox2 (<bold>G</bold>) or Neurod2 (<bold>H</bold>). n=3–5 embryos/condition. Scale bars, indicated. Error bars, S.D. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001. Student’s paired, two-tailed t-test (<bold>A</bold>), Two-way ANOVA with Sidak’s (<bold>E</bold>), Student’s unpaired, two-tailed t-test (<bold>G, H</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78203-fig2-v1.tif"/></fig><p>We next probed the functional redundancy of DDX3X and DDX3Y by investigating requirements for <italic>Ddx3y</italic> during cortical development. To this end, we performed <italic>in utero</italic> electroporation (IUE) of E14.5 brains with <italic>Ddx3y</italic> sgRNA + Cas9 and pCAG-GFP to deplete <italic>Ddx3y</italic> in males (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Using FACS to isolate GFP+ cells from E17.5 brains, we quantified an average 53% reduction in <italic>Ddx3y</italic> mRNA levels following <italic>Ddx3y</italic> CRISPR-based depletion; there was no effect upon <italic>Ddx3x</italic> mRNA expression (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). This indicates that <italic>Ddx3y</italic> sgRNAs are specific and effective.</p><p>We next assessed the requirement of <italic>Ddx3y</italic> for neurogenesis. In control E17.5 male brains (no sgRNA) GFP-positive cells were distributed fairly evenly across cortical bins (<xref ref-type="fig" rid="fig2">Figure 2D, E</xref>). Conversely, <italic>Ddx3y</italic> knockdown led to the accumulation of GFP+ cells in the VZ, with few GFP+ cells in the CP (<xref ref-type="fig" rid="fig2">Figure 2D, E</xref>). This defect could be due to impaired migration and/or altered production of neurons. Quantification of GFP+Sox2+ progenitors and GFP+Neurod2+ neurons showed that <italic>Ddx3y</italic> depletion led to significantly more progenitors and fewer neurons, as compared to control (<xref ref-type="fig" rid="fig2">Figure 2F–H</xref>). Importantly, these findings phenocopy acute <italic>Ddx3x</italic> knockdown by IUE in the embryonic brain (<xref ref-type="bibr" rid="bib39">Lennox et al., 2020</xref>). This demonstrates that <italic>Ddx3x</italic> and <italic>Ddx3y</italic> have similar requirements for neurogenesis, suggesting that <italic>Ddx3y</italic> partially compensates for <italic>Ddx3x</italic> in cKO males. This finding may explain the divergent phenotypes of cKO male and female mice, as well as why some <italic>DDX3X</italic> mutations in human males are tolerated.</p></sec><sec id="s2-3"><title><italic>Ddx3x</italic> cHet female and cKO male brains have more progenitors and fewer neurons</title><p>Because <italic>DDX3X</italic> syndrome females are heterozygous and males are hemizygous, we focused our analyses on cHet females and cKO males. Importantly, both genotypes have similar 30–40% reduction in <italic>Ddx3x</italic> mRNA relative to their sex-matched controls and normal brain size (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Moreover, redundant functions of DDX3X and DDX3Y, along with transcriptional upregulation of <italic>Ddx3y</italic> in cKO males likely equalizes total DDX3 levels in cHet females and cKO males. This provides a rationale for evaluating both sexes to investigate requirements of <italic>Ddx3x</italic> in cortical development. For simplicity, going forward we collectively refer to the cHet females and cKO males as <italic>Ddx3x</italic> depleted.</p><p>Our data using both <italic>Emx1</italic>- and <italic>Nex</italic>-Cre drivers suggests that <italic>Ddx3x</italic> LoF impairs cortical development by specifically controlling progenitors. We thus quantified progenitors in <italic>Emx1</italic>-Cre, <italic>Ddx3x</italic> depleted brains at E13.5 and E14.5, stages at which both RGCs and IPs are abundant (<xref ref-type="fig" rid="fig3">Figure 3</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Compared to E13.5 control mice, <italic>Ddx3x</italic> depleted brains showed similar numbers of mature IPs (Tbr2+Sox2-), although RGCs (Sox2+) trended higher (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–C</xref>). However, by E14.5, the number of RGCs and mature IPs was significantly increased in <italic>Ddx3x</italic> depleted brains (<xref ref-type="fig" rid="fig3">Figure 3A–C</xref>). Moreover, there was a concomitant trend towards fewer Tbr2-Sox2- cells following <italic>Ddx3x</italic> depletion at both E13.5 and E14.5, suggesting potentially fewer neurons (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D, E</xref>). These alterations in cell composition did not significantly impact overall cortical thickness at E14.5, although there was a slight trend in reduced medial thickness (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F</xref>). These results are overall consistent with the lack of microcephaly in these mice (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>Ddx3x</italic> depletion leads to more RGCs and mature IPs, and fewer excitatory neurons across laminar layers.</title><p>(<bold>A</bold>) Representative sections from E14.5 cortices stained with Sox2 (magenta) and Tbr2 (green) (control M and cKO M shown). (<bold>B, C</bold>) Quantification of density of Sox2+ (RGCs) (<bold>B</bold>) and Tbr2 +Sox2- (mature IPs) (<bold>C</bold>) cells relative to all cells (Hoechst) at E14.5. n=7–8 embryos/condition. (<bold>D</bold>) Representative sections stained with Ctip2 (green), Tbr1 (red), and Lhx2 (green) from P0 control and cHet F/cKO M cortices (control M and cKO M shown). (<bold>E–G</bold>) Quantification of laminar marker density for Tbr1 (<bold>E</bold>), Ctip2 (<bold>F</bold>), and Lhx2 (<bold>G</bold>) relative to all cells (Hoechst). n=8–10 embryos/condition. Scale bars, indicated. Error bars, S.D. *p&lt;0.05, **p&lt;0.01. Student’s unpaired, two-tailed t-test (<bold>B, C, E–G</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78203-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title><italic>Ddx3x</italic> depletion leads to more progenitors and less neurons at E13.5, but does not affect cortical thickness or laminar position of neurons.</title><p>(<bold>A</bold>) Representative coronal sections from control and cHet F/cKO M at E13.5 immunostained with Sox2 (green), Tbr2 (magenta) and Hoechst (control M and cKO M shown). (<bold>B–E</bold>) Quantification of RGCs (Sox2+) (<bold>B</bold>), mature IPs (Sox2-,Tbr2+) (<bold>C</bold>), putative neurons (Sox2-Tbr2-), density relative to Hoechst in control and cHet F/cKO M at E13.5 (<bold>D</bold>). n=6–9 embryos/condition. Sox2-Tbr2- density relative to Hoechst in control and cHet F/cKO M at E14.5. n=7–8 embryos/condition (<bold>E</bold>). (<bold>F</bold>) Quantification of cortical thickness at E14.5 in control and cHet F/cKO M measured medially and laterally (total) or just medially. n=12–17 embryos/condition. (<bold>G, H</bold>) Quantification of the distribution of Tbr1+ (<bold>G</bold>) and Ctip2+ (<bold>H</bold>) cells in control and cHet F/cKO M at P0. Student’s unpaired, two-tailed t-test (<bold>B–F</bold>), Two-way ANOVA with Sidak’s (<bold>G, H</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78203-fig3-figsupp1-v1.tif"/></fig></fig-group><p>We next assessed how these cell composition differences ultimately impact excitatory neuron number and laminar organization in P0 brains. The number of Tbr1 (Layer VI) and Ctip2 (Layer V) neurons was significantly reduced in <italic>Ddx3x</italic> depleted mice, and there was a trend towards reduced Lhx2 (Layer II/III) (<italic>P</italic>=0.078) (<xref ref-type="fig" rid="fig3">Figure 3D–G</xref>). However, laminar distribution was unaffected, suggesting that <italic>Ddx3x</italic> is largely dispensable for neuronal migration (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1G, H</xref>). These data indicate that <italic>Ddx3x</italic> is essential for proper neuron number and suggests it is required across all stages of corticogenesis.</p></sec><sec id="s2-4"><title><italic>Ddx3x</italic> conditional heterozygous progenitors exhibit a longer cell cycle and undergo less neurogenic divisions</title><p>We next aimed to understand the cell biological mechanisms by which <italic>Ddx3x</italic> depletion impairs progenitor and neuron number. One possibility is that <italic>Ddx3x</italic> depleted progenitors re-enter the cell cycle rather than exiting and terminally differentiating. To investigate this, we quantified cell cycle exit in E14.5 <italic>Ddx3x</italic> depleted embryos, using a 24-hr pulse of the nucleotide analog, EdU, at E13.5. EdU+Ki67- cells have exited the cell cycle and terminally differentiated, whereas EdU+Ki67+ cells are still progressing through the cell cycle. At E14.5, there were significantly more EdU+Ki67+ cells in <italic>Ddx3x</italic> depleted brains relative to control (<xref ref-type="fig" rid="fig4">Figure 4A–C</xref>), indicating that <italic>Ddx3x</italic> is required for progenitor cell cycle exit.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>Ddx3x</italic> depletion impairs progenitor cell cycle exit and prolongs cell cycle duration.</title><p>(<bold>A</bold>) Representative sections stained with Ki67 (green) and EdU (magenta) from E14.5 control and cHet F/cKO M mice (control F and cHet F shown) pulsed with EdU at E13.5, and higher magnification insets (A1, A2). (<bold>B, C</bold>) Quantification of Ki67 +EdU + relative to EdU + cells (<bold>B</bold>) and all cells (Hoechst, <bold>C</bold>). n=3–5 embryos/condition. (<bold>D, E</bold>) Quantification of EdU +Sox2+ (<bold>D</bold>) and EdU +Sox2-Tbr2- cells (<bold>E</bold>) relative to all EdU + cells. n=3–5 embryos/condition. (<bold>F</bold>) Schematic illustrating the semi-cumulative labeling paradigm and cell cycle formulas. <xref ref-type="fig" rid="fig4">Figure 4F</xref> has been adapted from Figure 4J from <xref ref-type="bibr" rid="bib6">Boyd et al., 2015</xref>. (<bold>G</bold>) Representative medial sections of E14.5 control and cHet F/cKO M brains stained with Ki67 (green), EdU (red) and BrdU (magenta) and pulsed with EdU and BrdU (control M and cKO M shown). Arrows indicate EdU +BrdU cells (i.e: leaving cells). (<bold>H</bold>) Quantification of cell cycle duration (Tc) in control and cHet F/cKO M. n=5–7 embryos/condition. (<bold>I</bold>) Quantification of Ts/Tc in control and cHet F/cKO M. n=5–7 embryos/condition. Scale bars, indicated. Error bars, S.D. *p&lt;0.05, **p&lt;0.01. Student’s unpaired, two-tailed t-test (<bold>B–E, H, I</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78203-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title><italic>Ddx3x</italic> depletion prolongs cell cycle duration in RGCs and immature IPs but does not affect mitosis duration.</title><p>(<bold>A</bold>) Representative coronal sections from control and cHet F/cKO M at E14.5 immunostained with Sox2 (green), Tbr2 (red), EdU (magenta) and Hoechst (control F and cHet F shown). (<bold>B</bold>) Quantification of density of mature IPs (EdU+Sox2-Tbr2+) relative to total EdU in control and cHet F/cKO M at E14.5. n=3–5 embryos/condition. (<bold>C</bold>) Representative coronal sections from control and cHet F/cKO M at E14.5 immunostained with Sox2 (green), PH3 (magenta), and Hoechst (control M and cKO M shown). (<bold>D</bold>) Quantification of PH3+Sox2+/Sox2+ in control and cHet F/cKO M. n=8–9 embryos/condition. (<bold>E</bold>) Quantification of mitosis duration in control and cHet F/cKO M at E14.5 from live imaging analysis. n=&gt;100 cells/condition/trial with three trials. Student’s unpaired, two-tailed t-test (<bold>B, D, E</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78203-fig4-figsupp1-v1.tif"/></fig></fig-group><p>In order to investigate whether <italic>Ddx3x</italic> depletion specifically impaired cell cycle exit of RGCs, IPs, or both, we quantified EdU+RGCs and IPs using Sox2 and Tbr2, respectively. We measured significantly more EdU+Sox2+ cells in <italic>Ddx3x</italic> depleted brains compared to control, indicating reduced cell cycle exit of RGCs (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). We did not observe a change in mature IPs (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A, B</xref>). Moreover, there was a significant concomitant decrease in EdU+Sox2-Tbr2- cells (putative neurons) in <italic>Ddx3x</italic> depleted brains relative to control (<xref ref-type="fig" rid="fig4">Figure 4E</xref>), suggesting that <italic>Ddx3x</italic> depletion perturbs generation of neurons. Overall, these data demonstrate that <italic>Ddx3x</italic> depletion impairs cell cycle exit, predominantly in RGCs, resulting in generation of fewer excitatory neurons.</p><p>Based on these results, we posited that DDX3X controls neuron generation by impacting how progenitors divide. Indeed, DDX3X has a conserved role in regulating cell cycle in other contexts (<xref ref-type="bibr" rid="bib10">Chen et al., 2016a</xref>; <xref ref-type="bibr" rid="bib21">Heerma van Voss et al., 2018</xref>; <xref ref-type="bibr" rid="bib33">Kotov et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">Li et al., 2014</xref>). To directly test whether <italic>Ddx3x</italic> depletion affects cortical progenitor cell cycle, we employed an established semi-cumulative labeling strategy (<xref ref-type="fig" rid="fig4">Figure 4F</xref>; <xref ref-type="bibr" rid="bib54">Quinn et al., 2007</xref>). Briefly, at E14.5, EdU was injected intraperitoneally followed by a BrdU injection 1.5 hr later. At t=2 hr, embryonic brains were harvested and Ki67, EdU and BrdU were quantified. Strikingly, the <italic>Ddx3x</italic> depleted brains exhibited a significantly longer cell cycle (Tc) than control, nearly 1.5-fold longer (average 17 hr in ctrl vs 25 hr in cHet F/cKO M) (<xref ref-type="fig" rid="fig4">Figure 4G and H</xref>). However, <italic>Ddx3x</italic> depletion did not specifically impair S phase duration as Ts/Tc was not significantly different (<xref ref-type="fig" rid="fig4">Figure 4I</xref>). Further, there was no significant difference in the percentage of phospho-histone3 (PH3)+Sox2+ cells between controls and <italic>Ddx3x</italic> depleted brains (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C, D</xref>) indicating that G2/M length of RGCs is not specifically affected. Altogether, these data demonstrate that <italic>Ddx3x</italic> depletion prolongs overall cell cycle <italic>in vivo</italic>, without a clear bias towards any specific phase.</p><p>We next employed clonal live imaging to monitor both progenitor cell cycle duration and progeny generation (<xref ref-type="bibr" rid="bib51">Pilaz et al., 2016</xref>). Primary cultures were produced from E14.5 cHet females, cKO males, and controls, and progenitors were live imaged (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). After 24 hr, we fixed and stained cells to monitor direct progeny (<xref ref-type="fig" rid="fig5">Figure 5A, B</xref>). We did not observe any significant differences in mitosis duration (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>), which aligns with PH3 quantification at E14.5 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C, D</xref>). Consistent with a prolonged cell cycle duration, <italic>Ddx3x</italic> depleted cells underwent significantly fewer re-divisions relative to controls (<xref ref-type="fig" rid="fig5">Figure 5C–D</xref>). These data are consistent with the longer cell cycle measured <italic>in vivo</italic>, demonstrating that progenitors <italic>in vitro</italic> reflect <italic>in vivo</italic> phenotypes.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title><italic>Ddx3x-</italic>depleted progenitors exhibit prolonged cell division and more proliferative divisions at the expense of neurogenic divisions.</title><p>(<bold>A</bold>) Live imaging paradigm for monitoring cell fate. <xref ref-type="fig" rid="fig5">Figure 5A</xref> has been adapted from Figure 3A and E from <xref ref-type="bibr" rid="bib51">Pilaz et al., 2016</xref>. (<bold>B</bold>) Live imaging DIC snapshots at indicated t=minutes or hours, and fixed images stained with indicated markers. (<bold>C</bold>) Quantification of re-divisions (black) and 1 division (white) in control and cHet F/cKO M. n=304 (control) and 539 (cHet F/cKO M) total cells. (<bold>D</bold>) Schematic illustrating an example of a re-division. (<bold>E</bold>) Quantification of cell fate for P,P divisions (2 Sox2+ RGCs, or 2 Tbr2+ IPs, or 1 Sox2+ RGC and 1 Tbr2+Tuj1- IP); P, N divisions (1 Tuj1+ neuron and either 1 Sox2+ RGC or 1 Tbr2+ IP); N, N divisions (2 Tuj1+ neurons). n=&gt;70 cells/condition/trial with three trials. Scale bars, indicated. Error bars, S.D. *p&lt;0.05, ****p&lt;0.0001. Two-tailed Fisher’s exact test (<bold>C</bold>), Two-way ANOVA with Sidak’s correction (<bold>E</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78203-fig5-v1.tif"/></fig><p>Because <italic>Ddx3x</italic> depleted brains have a modest reduction in neurons, we also used live imaging to determine whether <italic>Ddx3x</italic> loss independently impairs the ability of progenitors to directly produce neurons. Following live imaging, cells were immunostained with Sox2, Tbr2, Tuj1 and Hoechst to discriminate between proliferative, asymmetric neurogenic, and symmetric neurogenic divisions (<xref ref-type="fig" rid="fig5">Figure 5A, B</xref>). <italic>Ddx3x</italic> depleted progenitors underwent significantly more proliferative (P,P) divisions and significantly fewer symmetric neurogenic (N,N) divisions relative to controls (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). Asymmetric neurogenic (N,P) divisions were unchanged. Consistent with CC3 staining at E14.5, there were virtually no apoptotic progeny in cHet females/cKO males and controls. These data demonstrate that, in addition to prolonged cell cycle, <italic>Ddx3x</italic>-deficient progenitors undergo more proliferative divisions and fewer symmetric neurogenic divisions.</p><p>Overall, these findings reveal that DDX3X controls neuron generation by acting in progenitors via two mechanisms. First, progenitor cell cycle duration is increased and progenitors are delayed in cell cycle exit, and second, progenitors that do exit the cell cycle tend to produce progenitors rather than neurons. This provides a mechanistic explanation for how <italic>Ddx3x</italic> controls cortical neuron generation.</p></sec><sec id="s2-5"><title>Ribosome profiling uncovers the translatome of E11.5 neural progenitors</title><p>We next sought to understand molecular mechanisms by which <italic>Ddx3x</italic> alters progenitor fate decisions and impairs neurogenesis. DDX3X is an RNA helicase with canonical requirements for translation initiation, particularly for mRNAs with structured 5′ UTRs (<xref ref-type="bibr" rid="bib9">Calviello et al., 2021</xref>). Neural progenitors can be transcriptionally primed which is thought to promote generation of specific cell fates (<xref ref-type="bibr" rid="bib22">Hoye and Silver, 2021</xref>; <xref ref-type="bibr" rid="bib41">Li et al., 2020</xref>). However, a lack of genome-wide translational data in the developing cortex has limited our understanding of how translational control influences neurogenesis. To investigate translation at the earliest stages of cortical development and to identify which mRNAs require DDX3X for their translation, we performed ribosome profiling (Ribo-seq) (<xref ref-type="bibr" rid="bib23">Ingolia, 2016</xref>) and RNA-seq using E11.5 microdissected cortices from cKO and control males and females (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). To ensure maximal <italic>Ddx3x</italic> depletion and have the highest sensitivity for identifying DDX3X-dependent translation targets, we focused on cKO females and males. Further, we employed Ribo-seq at E11.5 to avoid confounds due to apoptosis in the cKO females. At this stage, the brain is also largely homogenous composed of mainly neural progenitors. We optimized Ribo-seq on E11.5 cortices (see Materials and methods) and performed extensive quality control to ensure that ribosome-protected fragments (RPFs) were the correct size (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A, B</xref>), mapped to the coding region as expected (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>), and were in the correct reading frame (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D</xref>; see Materials and methods).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Ribosome Profiling in embryonic brains uncovers the E11.5 translatome including DDX3X-dependent translation targets.</title><p>(<bold>A</bold>) Experimental paradigm for Ribo-seq and RNAseq of E11.5 cortices from control and cKO mice. n=3/sex/condition with four embryos pooled per n. (<bold>B</bold>) TE of transcripts enriched in RGCs, IPs, deep layer neurons (VI-V) and superficial layer neurons (IV-II) relative to all other mRNAs (TPM &gt;10). Birthdates for laminar layers are indicated below. See <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> for exact transcripts. (<bold>C</bold>) ORFquant analysis of wildtype Ribo-seq data showing identification of annotated ORFs and uORFs in protein-coding and non-coding isoforms. (<bold>D</bold>) Schematic illustrating how DDX3X-dependent targets were prioritized. (<bold>E</bold>) Scatter plot of RPFs log2FC versus RNA log2FC for 59 DDX3X-dependent targets with significantly lower TE. Putative Ribo-seq targets selected for validation are highlighted in blue. (<bold>F</bold>) IGV screenshots illustrating RNAseq reads (gray) and RPFs (Ribo-seq; purple) for <italic>Topbp1</italic> in cKO mice relative to control. (<bold>G</bold>) Representative trace from polysome fractionation of E14.5 cortical lysate. (<bold>H–M</bold>) RT-qPCR quantification of mRNA levels for Ribo-seq candidates in input samples at E11.5 (<bold>H</bold>) and at E14.5 (<bold>I</bold>), and monosome and polysome fractions at E11.5 (<bold>J</bold>) and E14.5 (<bold>K–M</bold>). n=5–7/condition (<bold>H, J</bold>) and 4/condition (<bold>I, K–M</bold>) with two embryos pooled per n. Error bars, S.D. *p&lt;0.05, **p&lt;0.01. Two-sided Wilcoxon test (<bold>B</bold>), Student’s unpaired, two-tailed t-test (<bold>H–M</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78203-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Quality Control Assessment of Ribosome Profiling in <italic>Ddx3x</italic> cKO mice.</title><p>(<bold>A</bold>) Representative denaturing urea gel of embryonic cortices treated with RNase I illustrating RPFs (red box). (<bold>B–D</bold>) RibosomeProfilingQC assessment of deep sequencing of cDNA libraries showing read length distribution (<bold>B</bold>), percent of reads mapping to CDS and UTRs, etc (<bold>C</bold>), and reading frame (<bold>D</bold>). (<bold>E</bold>) Comparison of RNAseq cpm and Riboseq cpm using all reads from all transcripts from WT data (excluding non-polyA histone and multi-mapping ribosomal genes); Spearman <italic>r</italic>=0.9676. Five transcripts were omitted when reducing axes for readability. (<bold>F</bold>) <italic>De novo</italic> identification of translated ORFs, including number of detected ORFs with their length (in nucleotides) for different ORF categories and annotated biotypes. (<bold>G</bold>) A novel translated ORF in the lncRNA <italic>Rab26os</italic> showing the P-sites position colored by frame (middle), and ORF quant-derived annotation (bottom).</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Quality Control Assessment of Ribosome Profiling.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78203-fig6-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78203-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Polysome fractionation and RNA immunoprecipitations showing DDX3X targets in the cortex.</title><p>(<bold>A–C</bold>) RT-qPCR quantification of mRNA levels for Ribo-seq candidates in input samples, monosome and polysome fractions at E11.5 for <italic>Topbp1</italic> (<bold>A</bold>) and <italic>Setd3</italic> (<bold>B</bold>) and at E14.5 for <italic>Hax1</italic> (<bold>C</bold>). (<bold>D</bold>) Representative gels of RNA immunoprecipitation of DDX3X translation targets, <italic>Rcor2</italic>, <italic>Setd3</italic>, and <italic>Topbp1</italic>. n=5–7 embryos/condition (<bold>A, B</bold>), 4 embryos/condition (<bold>C</bold>), 3 biological replicates (<bold>D</bold>). Student’s unpaired, two-tailed t-test (<bold>A–C</bold>).</p><p><supplementary-material id="fig6s2sdata1"><label>Figure 6—figure supplement 2—source data 1.</label><caption><title>RNA immunoprecipitations of targets by DDX3X.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-78203-fig6-figsupp2-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78203-fig6-figsupp2-v1.tif"/></fig></fig-group><p>We first examined translational regulation of wildtype progenitors. Overall, we observed a correlation between RNA and RPF abundance (Spearman <italic>r</italic>=0.9676) (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E</xref>). Using translation efficiency (TE, a metric reflecting translation per mRNA), taking into account both transcript levels (RNA-seq) and ribosome occupancy (Ribo-seq) (see Materials and methods), we assessed whether transcripts are translationally regulated in wildtype E11.5 progenitors. Towards this, we focused on TE of canonical mRNAs known to be enriched in RGCs, IPs, and deep (VI-V) and superficial layer (IV-II) neurons (<xref ref-type="bibr" rid="bib13">Di Bella et al., 2021</xref>; <xref ref-type="bibr" rid="bib64">Telley et al., 2019</xref>) (see <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>) as compared to all other genes. We expected that RGC-enriched genes would be highly expressed and translated since RGCs are a predominant cell type at E11.5. IPs and deep layer neurons are produced beginning at E11.5 and E12.5, respectively. In contrast, superficial layer neurons are born later (E13.5-E17.5), and thus, we expected lower translation of these genes. To our surprise we found that at E11.5, RGC-, IP-, and deep layer neuron-enriched transcripts all had significantly higher TE than the average transcript expressed at this stage (other genes), consistent with translational upregulation (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Moreover, there was a notable divergence between deep (positive TE) and superficial (negative TE) layer neuron transcripts (<xref ref-type="fig" rid="fig6">Figure 6B</xref>), suggesting superficial layer neuron transcripts are translationally repressed. This suggests that in addition to transcriptional priming, early progenitors also use translational priming to direct cell fate. Moreover, these results indicate that observed differences in TE might reflect developmental stepwise translational repression.</p><p>Ribo-seq can also reveal the use of upstream open reading frames (uORFs), which frequently cause translational repression of the downstream, canonical ORF (<xref ref-type="bibr" rid="bib28">Johnstone et al., 2016</xref>). We thus used ORFquant to assess canonical ORFs and uORFs in cortical progenitors (<xref ref-type="bibr" rid="bib8">Calviello et al., 2020</xref>). This revealed ~14,000 annotated ORFs and ~2500 uORFs, including a prominent uORF in the lissencephaly gene, <italic>Pafah1b1</italic> or <italic>Lis1</italic> (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). We also identified ~1200 ORFs in non-coding RNAs, including a novel ORF in the <italic>Rab26os</italic> lncRNA (<xref ref-type="fig" rid="fig6">Figure 6C</xref>; <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1F</xref>, G). Thus, this rich dataset provides a valuable resource to interrogate the use of uORFs during cortical development and suggests an important mode of gene expression regulation in the developing cortex. Overall, these high-quality Ribo-seq data will enable the generation of novel hypotheses regarding translational control and cortical development.</p></sec><sec id="s2-6"><title>DDX3X-dependent translation targets are critical for neurogenesis</title><p>We then turned to our <italic>Ddx3x</italic> cKO data to discover DDX3X-dependent translation targets and identified 147 targets that had differential TE (p-adjusted &lt;0.05) (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). The low number of DDX3X translation targets is on-par with translational studies of DDX3X in immortalized cells and reinforces that DDX3X is not a general translation factor (<xref ref-type="bibr" rid="bib9">Calviello et al., 2021</xref>). Virtually all targets (144 of 147) had a lower TE in cKO mice, consistent with DDX3X promoting translation. About half of these TE changes were driven by changes in the input RNA levels while the other half had significantly lower TE with little to no change in the corresponding input RNA. We thus focused on the 59 targets in which the input RNA was &lt;0.5 log2FC, as these are most likely to be <italic>bona fide</italic> DDX3X translation targets (<xref ref-type="fig" rid="fig6">Figure 6D, E</xref>). <italic>Rcor2</italic>, <italic>Setd3</italic>, and <italic>Topbp1</italic>, were amongst those targets showing a general decrease in RPFs along the mRNA, adjusted p&lt;0.05 (<xref ref-type="fig" rid="fig6">Figure 6E, F</xref>).</p><p>To orthogonally evaluate these DDX3X-dependent translational targets, we employed polysome fractionation using E11.5 cortices of cKO females and cKO males, as well as controls (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). Therefore, we isolated RNA from the monosome and high molecular weight (HMW) polysome fractions and performed RT-qPCR of putative DDX3X translation targets. We observed that <italic>Rcor2</italic> and <italic>Topbp1</italic> mRNA were signficantly enriched in the monosome fraction of cKO females and males relative to controls, while the HMW polysome fraction was unaltered (<xref ref-type="fig" rid="fig6">Figure 6J</xref>, <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A</xref>). Similar trends were seen with <italic>Setd3</italic> (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2B</xref>). Of note, the input RNA levels of <italic>Rcor2</italic> trended to be elevated in cKO cortices as compared to controls (<xref ref-type="fig" rid="fig6">Figure 6H</xref>, <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2A, B</xref>), consistent with the Ribo-seq/RNA-seq results.</p><p>To further validate the translational targets and to assess targets that may reflect cell composition changes, we performed polysome fractionation at E14.5 again using cKO males and also cHet females (<xref ref-type="fig" rid="fig6">Figure 6G</xref>). We did not include E14.5 cKO females given the profound cell death evident at this timepoint (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Both <italic>Rcor2</italic> and <italic>Setd3</italic> were significantly enriched in the monosome fraction and significantly depleted from the polysome fraction for cHet females/cKO males as compared to controls (<xref ref-type="fig" rid="fig6">Figure 6K, L</xref>), consistent with their decreased TE at E11.5. <italic>Topbp1</italic> was significantly depleted from the polysome fraction, but unchanged in the monosome fraction in cHet females/cKO males relative to controls (<xref ref-type="fig" rid="fig6">Figure 6M</xref>). Another putative target, <italic>Hax1,</italic> showed trends to shift from polysomes (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C</xref>). Interestingly, <italic>Rcor2</italic>, <italic>Setd3,</italic> and <italic>Topbp1</italic> were also significantly upregulated in the input RNA at E14.5 (<xref ref-type="fig" rid="fig6">Figure 6I</xref>) as compared to controls, even though their RNA levels were not significantly changed at E11.5. These shifts of DDX3X-dependent translation targets towards monosomes and concomitant depletion from polysomes were specific. For example, <italic>β-actin</italic> levels, were comparable between monosome fractions (<italic>β-actin</italic> CT average 25.06 vs 24.58) and polysome fractions (<italic>β-actin</italic> CT average 22.73 vs 22.72) of cHet females/cKO males and controls. Altogether the shift towards monosomes along with reduced TE reflects an essential requirement of DDX3X for translation of specific mRNAs in cortical progenitors <italic>in vivo</italic>.</p><p>We next asked whether DDX3X binds to these translational targets. Using RNA immunoprecipitations (RIP)(<xref ref-type="bibr" rid="bib31">Keene et al., 2006</xref>), we transiently transfected N2A cells with GFP-hDDX3X and performed GFP pulldowns to isolate bound RNAs. RT-PCR for <italic>Rcor2</italic>, <italic>Setd<underline>3</underline></italic>, and <italic>Topbp1</italic>, revealed specific binding to these transcripts by GFP-hDDX3X, but not in untransfected cells (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2D</xref>).</p><p>We then queried whether any of these translation targets had known roles in neurogenesis. RCOR2 is critical for neural proliferation (<xref ref-type="bibr" rid="bib46">Monaghan et al., 2017</xref>; <xref ref-type="bibr" rid="bib68">Wang et al., 2016</xref>), and <italic>Topbp1</italic> deletion in neural progenitors results in DNA damage and apoptosis (<xref ref-type="bibr" rid="bib38">Lee et al., 2012</xref>). These requirements are notably similar to <italic>Ddx3x</italic> LoF, indicating that DDX3X-dependent translational targets are critical within neural progenitors for cortical development.</p><p>Another DDX3X-dependent target, <italic>Setd3</italic>, is expressed in the developing cortex (<xref ref-type="bibr" rid="bib64">Telley et al., 2019</xref>), but its requirements for corticogenesis are unknown. SETD3 is a histidine methyltransferase, which may modify histone H3, as well as actin H73 (<xref ref-type="bibr" rid="bib72">Witecka et al., 2021</xref>). Consistent with this, <italic>Setd3</italic> is implicated in cancer progression and cell cycle control, as well as cytoskeletal integrity (<xref ref-type="bibr" rid="bib72">Witecka et al., 2021</xref>). To test the requirements of <italic>Setd3</italic> for cortical development, we validated siRNAs by knockdown <italic>Setd3</italic> in N2A cells and observed a ~50% reduction after 24 hours (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). We then performed IUEs to deliver either scrambled or <italic>Setd3</italic> siRNAs, along with pCAG-GFP, at E14.5 and collected embryos at E17.5. <italic>Setd3</italic> knockdown significantly altered the distribution of GFP + cells, with significantly more cells in the VZ and fewer cells in the CP (<xref ref-type="fig" rid="fig7">Figure 7B, C</xref>). Moreover, <italic>Setd3</italic> knockdown resulted in more Sox2+ RGCs and fewer Neurod2+ neurons (<xref ref-type="fig" rid="fig7">Figure 7D, E</xref>), phenocopying <italic>Ddx3x</italic> LoF. This suggests that decreased TE of <italic>Setd3,</italic> as well as other DDX3X-dependent targets, may synergistically contribute to <italic>Ddx3x</italic> LoF neurogenesis phenotypes (<xref ref-type="fig" rid="fig7">Figure 7F</xref>). Taken together these data show that DDX3X controls translation of a repertoire of genes which are collectively critical in neural progenitors for neurogenesis.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>DDX3X-dependent translation target, <italic>Setd3</italic>, is required for neurogenesis.</title><p>(<bold>A</bold>) RT-qPCR quantification of <italic>Setd3</italic> knockdown in N2A cells. n=4/condition with two independent trials. (<bold>B</bold>) Representative sections of E17.5 brains from mice electroporated at E14.5 with pCAG-GFP and scrambled or <italic>Setd3</italic> siRNAs and immunostained with GFP (grey), Sox2 (magenta), Neurod2 (green). (<bold>C</bold>) Quantification of distribution of GFP-positive cells in 5 even bins of cortex. n=4 embryos/condition. (<bold>D, E</bold>) Quantification of GFP co-localization with Sox2+ (<bold>D</bold>) and Neurod2+ (<bold>E</bold>) cells. n=4 embryos/condition. (<bold>F</bold>) Schematic model summarizing how loss of DDX3X-dependent translation impairs neurogenesis. Scale bars, indicated. Error bars, S.D. *p&lt;0.05, ****p&lt;0.0001. Student’s unpaired, two-tailed t-test (<bold>A, D, E</bold>), Two-way ANOVA with Sidak’s correction (<bold>C</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78203-fig7-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Mutations in <italic>DDX3X</italic> are a leading cause of ID, as well as other developmental phenotypes, which are classified as <italic>DDX3X</italic> syndrome (<xref ref-type="bibr" rid="bib3">Beal et al., 2019</xref>; <xref ref-type="bibr" rid="bib27">Johnson-Kerner et al., 1993</xref>; <xref ref-type="bibr" rid="bib39">Lennox et al., 2020</xref>; <xref ref-type="bibr" rid="bib59">Snijders Blok et al., 2015</xref>; <xref ref-type="bibr" rid="bib69">Wang et al., 2018</xref>). Half of the over 100 known <italic>DDX3X</italic> mutations are nonsense, predicted to act in a LoF manner. Yet, the molecular and cellular mechanisms by which <italic>Ddx3x</italic> LoF perturbs cortical development have been largely unknown. Here, we leveraged a new genetic model of <italic>Ddx3x</italic> LoF to discover that DDX3X promotes neuronal generation by regulating the length and fate of progenitor divisions, namely RGCs and IPs. We further use <italic>in vivo</italic> Ribo-seq to define the repertoire of transcripts whose translation depends upon DDX3X, many of which are critical for neurogenesis. Our results provide invaluable new insights into the underpinnings of <italic>DDX3X</italic> syndrome and biology, and highlight candidate targets and possible pathways for therapeutic intervention.</p><sec id="s3-1"><title><italic>Ddx3x</italic> dosage underlies cell fate and sexually dimorphic phenotypes</title><p>While the vast majority of <italic>DDX3X</italic> syndrome individuals are female, an increasing number of male individuals have been identified (<xref ref-type="bibr" rid="bib32">Kellaris et al., 2018</xref>; <xref ref-type="bibr" rid="bib47">Nicola et al., 2019</xref>), comprising ~5% of all cases (ddx3x.org). Using our conditional mouse model, we interrogated phenotypic overlap in males and females, as well as the role of the paralog <italic>Ddx3y</italic>. Complete loss of <italic>Ddx3x</italic> led to microcephaly in females, but not in hemizygous males, suggesting that brain development is sexually dimorphic. We posit that <italic>Ddx3y</italic> expression explains why cKO male mice are phenotypically milder than cKO females; we found that <italic>Ddx3y</italic> loss phenocopies <italic>Ddx3x</italic> neurogenesis defects. Likewise, in both the hindbrain and hematopoietic system, <italic>Ddx3y</italic> can also compensate for loss of <italic>Ddx3x in vivo</italic> (<xref ref-type="bibr" rid="bib49">Patmore et al., 2020</xref>; <xref ref-type="bibr" rid="bib60">Szappanos et al., 2018</xref>). The ability of <italic>Ddx3y</italic> to compensate for <italic>Ddx3x</italic> loss may be due in part to redundant translational regulation (<xref ref-type="bibr" rid="bib67">Venkataramanan et al., 2021</xref>), as well as transcriptional adaptation of <italic>Ddx3y</italic> in response to <italic>Ddx3x</italic> loss (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Taken together these data provide a possible explanation for why males carrying <italic>DDX3X</italic> mutations are viable (<xref ref-type="bibr" rid="bib32">Kellaris et al., 2018</xref>; <xref ref-type="bibr" rid="bib39">Lennox et al., 2020</xref>; <xref ref-type="bibr" rid="bib47">Nicola et al., 2019</xref>). Because <italic>Ddx3x</italic> partially escapes XCI in females (<xref ref-type="fig" rid="fig1">Figure 1</xref>), we hypothesize that DDX3Y normalizes total DDX3 levels between males and females; this may explain why cHet females and cKO males have comparable phenotypes.</p><p>In addition to being sexually dimorphic, we discover that neural cells of the developing cortex are sensitive to <italic>Ddx3x</italic> knockout, as loss of one versus two copies causes vastly different corticogenesis phenotypes. In the case of cKO females, there is profound apoptosis in progenitors and neurons, whereas cHet females and cKO males have impaired neurogenesis without cell death. This sensitivity of the developing brain to <italic>Ddx3x</italic> is highly relevant for interpreting the spectrum of mutations annotated as nonsense. For example, there may be nonsense mutations that act as a pure LoF (i.e.: an N-terminal mutation that undergoes NMD) as well as mutations that are hypomorphic (i.e.: a C-terminal mutation that escapes NMD and might have some functional protein activity).</p></sec><sec id="s3-2"><title><italic>Ddx3x</italic> is required for neural progenitor cell division which underlies cortical abnormalities</title><p>We show that DDX3X controls the function of neural progenitors and generation of excitatory neurons throughout cortical development through two key mechanisms. First, <italic>Ddx3x</italic> depletion increases progenitor cell cycle duration by 1.4-fold. It does so without altering any specific phase, consistent with a study of DDX3X in cancer cells using FUCCI (<xref ref-type="bibr" rid="bib21">Heerma van Voss et al., 2018</xref>). Additionally, <italic>Ddx3x</italic> depleted progenitors <italic>in vitro</italic> underwent fewer re-divisions in a 24-hr period; if this increase in cell cycle duration were sustained over the course of neurogenesis, we predict it would result in overall fewer progenitor divisions, and ultimately fewer neurons (<xref ref-type="bibr" rid="bib61">Takahashi et al., 1995</xref>). Consistent with this, neurons were modestly reduced across laminar layers at P0 in <italic>Ddx3x</italic> mutants. Second, <italic>Ddx3x</italic> controls the balance of proliferative versus neurogenic divisions, resulting in reduced generation of neurons. This is particularly fascinating as it demonstrates that DDX3X functions in progenitors to direct neural fates of daughter progeny. Our Ribo-seq suggests that these cellular mechanisms might be influenced by translational control in progenitors.</p><p>Going forward, it will be important to further dissect how DDX3X dosage influences neural progenitor cell cycle and cell fate. <italic>Ddx3x</italic> depletion had a particularly potent impact on RGCs, relative to IPs, suggesting that RGCs may be especially sensitive to loss of DDX3X, which is consistent with higher <italic>Ddx3x</italic> expression in RGCs relative to IPs (<xref ref-type="bibr" rid="bib64">Telley et al., 2019</xref>). Moreover, this could reflect differences in cell cycle duration of these progenitors (<xref ref-type="bibr" rid="bib1">Arai et al., 2011</xref>).</p><p>Using a conditional mouse model provided distinct advantages to propel our understanding of <italic>Ddx3x</italic> requirements during cortical development. New insights into <italic>Ddx3x</italic> dosage requirements and redundant roles of DDX3X and DDX3Y would not have been gained with germline LoF models, due to male lethality (<xref ref-type="bibr" rid="bib10">Chen et al., 2016a</xref>). A recent report assessed behavioral phenotypes of a germline mouse model of <italic>Ddx3x</italic> haploinsufficiency in females (<xref ref-type="bibr" rid="bib5">Boitnott et al., 2021</xref>). Consistent with our cHet phenotypes, these females were not grossly microcephalic, but did have reduced Ctip2+ (layer V) neurons in the somatosensory cortex at P3, which persisted into adulthood. These germline mice also have overall gross delay, defects in motor coordination, and sensory behavioral abnormalities. Our study thus provides valuable insights to explain the embryonic underpinnings of these behavioral deficits. Finally, while our analyses cannot rule out subtle brain size defects in cHet females, overall our findings are consistent with the human syndrome where the microcephaly is mild or absent in individuals with nonsense mutations (<xref ref-type="bibr" rid="bib39">Lennox et al., 2020</xref>).</p><p>We also gained new insights into cell-autonomous <italic>Ddx3x</italic> requirements in brain development. Using a <italic>Nex</italic>-Cre cKO mouse model, we found that <italic>Ddx3x</italic> is largely dispensable in newborn neurons for their migration and survival, indicating that observed neuronal loss largely arises from impairments in neural progenitors. However, <italic>Ddx3x</italic> does control neurite outgrowth (<xref ref-type="bibr" rid="bib11">Chen et al., 2016b</xref>) and is a component of neuronal transport granules (<xref ref-type="bibr" rid="bib15">Elvira et al., 2006</xref>; <xref ref-type="bibr" rid="bib30">Kanai et al., 2004</xref>), suggesting it could function in mature neurons. DDX3X likely functions in other CNS cell types, as well, as 50% of <italic>DDX3X</italic> syndrome individuals present with white matter loss (<xref ref-type="bibr" rid="bib39">Lennox et al., 2020</xref>), which could arise from impaired gliogenesis. Indeed, Perturb-seq of 30 ASD-risk genes found that <italic>Ddx3x</italic> depletion alters oligodendrocyte gene expression (<xref ref-type="bibr" rid="bib26">Jin et al., 2020</xref>). Moreover, <italic>DDX3X</italic> also regulates innate immunity (<xref ref-type="bibr" rid="bib60">Szappanos et al., 2018</xref>), raising the intriguing idea that <italic>Ddx3x</italic> could function in microglia to influence cortical development. Thus, roles for <italic>Ddx3x</italic> in glial cells and mature neurons should be explored further.</p></sec><sec id="s3-3"><title>Translation during cortical development and DDX3X-dependent translational control of progenitors</title><p>In the neurodevelopment field there is a wealth of transcriptomic data, but far less translation/proteomic data for embryonic mouse cortex. Using Ribo-seq, we have generated a valuable new resource for understanding translation at the onset of neurogenesis. To our knowledge, this is one of the first reports to assess wildtype translation using Ribo-seq at the onset of neurogenesis, with exception of a recent pre-print which examined later stages of development (<xref ref-type="bibr" rid="bib20">Harnett et al., 2021</xref>). scRNAseq studies have revealed that transcripts important for deep and superficial layer neuronal fates are expressed in RGCs <xref ref-type="bibr" rid="bib64">Telley et al., 2019</xref>; however, it’s generally thought that these are translationally repressed until neurons are born. Intriguingly, our data show that deep layer transcripts have a higher TE than superficial layer transcripts, approaching that of RGCs and IPs. This suggests that there could be translational priming of progenitors, in addition to transcriptional priming. Given the instrumental role that translational factors play in cortical development (<xref ref-type="bibr" rid="bib22">Hoye and Silver, 2021</xref>; <xref ref-type="bibr" rid="bib34">Kraushar et al., 2014</xref>; <xref ref-type="bibr" rid="bib74">Yang et al., 2014</xref>; <xref ref-type="bibr" rid="bib76">Zahr et al., 2018</xref>), our data thus provides valuable targets which can be functionally tested at neuroepithelial stages and beyond.</p><p>Although DDX3X is a known translation regulator (<xref ref-type="bibr" rid="bib9">Calviello et al., 2021</xref>; <xref ref-type="bibr" rid="bib48">Oh et al., 2016</xref>), a key gap has been the identification of its targets in the developing brain. Using Ribo-seq, we discovered DDX3X-dependent targets in neural progenitors <italic>in vivo</italic>. Both <italic>Rcor2</italic> and <italic>Topbp1</italic> have known roles in cortical neurogenesis and we further established new requirements for <italic>Setd3</italic>. Both <italic>Rcor2</italic> and <italic>Setd3</italic> are epigenetic regulators (<xref ref-type="bibr" rid="bib68">Wang et al., 2016</xref>), suggesting their decreased TE may alter gene expression and cell fate. Notably, epigenetic regulators can influence gene expression by complexing with transcription factors. Indeed, RCOR2 binds to Insulinoma-associated 1 (<xref ref-type="bibr" rid="bib46">Monaghan et al., 2017</xref>), a transcription factor required in IPs for neurogenesis (<xref ref-type="bibr" rid="bib16">Farkas et al., 2008</xref>). DDX3X-mediated epigenetic regulation will be fascinating to investigate in future studies, especially considering that many epigenetic regulators and chromatin-modifying enzymes are implicated in ID and ASD (<xref ref-type="bibr" rid="bib19">Grafodatskaya et al., 2010</xref>). In sum, our translational analysis highlights new downstream pathways relevant for DDX3X function and disease pathology.</p><p>We speculate that reduced TE of DDX3X-dependent transcripts collectively contributes to phenotypes in mouse models and perhaps in human <italic>DDX3X</italic> syndrome. Given that <italic>Ddx3x</italic> LoF modestly affects TE of many transcripts in neural progenitors, we do not anticipate that increasing TE of any one transcript would alleviate <italic>Ddx3x</italic> LoF phenotypes. However, understanding how DDX3X is recruited to these transcripts to specifically promote translation initiation might uncover valuable mechanisms by which transcripts with low TE could be boosted translationally for therapeutic intervention. Likewise, elucidating RNA structures of these targets might lead to development of therapeutic small molecules which can overcome DDX3X-dependent translation.</p><p>Interestingly, DDX3X-dependent translation targets were shifted from polysomes to monosomes, consistent with reduced TE and a role for DDX3X in translational initiation. However, the basal RNA expression of DDX3X targets was also higher at E14.5 compared to E11.5. This could be explained by developmental differences in DD3X levels. Alternatively, it could suggest that reduced TE of DDX3X-dependent targets leads to a feedback mechanism whereby these mRNAs are transcriptionally upregulated over time. This potential feedback loop is relevant for those pursuing Ribo-seq experiments to consider, as putative targets are typically defined by RPF density changes but not the input RNA (<xref ref-type="bibr" rid="bib23">Ingolia, 2016</xref>).</p></sec><sec id="s3-4"><title>The landscape of DDX3X mutations with divergent phenotypes</title><p>Our work further substantiates the importance of post-transcriptional RNA regulation in cortical development and disease. There is a strong association between mutations in translation regulators and neurodevelopmental disorders (<xref ref-type="bibr" rid="bib12">Chen et al., 2019</xref>; <xref ref-type="bibr" rid="bib22">Hoye and Silver, 2021</xref>). As we have shown, investigation of DDX3X and translational regulators can give valuable insights into the etiology of these disorders by discovering networks of neurogenesis regulation including crucial factors such as SETD3.</p><p>Our work also provides a mechanistic understanding of how <italic>Ddx3x</italic> LoF impairs embryonic cortical development; this may model human <italic>DDX3X</italic> nonsense mutations that result in haploinsufficiency. The extent to which these mechanisms extend to all mutations is unknown. Indeed, it is imperative to define how the full spectrum of <italic>DDX3X</italic> mutations impact its expression and ultimately, influence corticogenesis. Half of <italic>DDX3X</italic> mutations are missense, with a subset showing more clinically severe outcomes relative to those carrying nonsense mutations (<xref ref-type="bibr" rid="bib39">Lennox et al., 2020</xref>). Interestingly, <italic>DDX3X</italic> missense mutations might differentially impair translation of DDX3X targets (<xref ref-type="bibr" rid="bib9">Calviello et al., 2021</xref>; <xref ref-type="bibr" rid="bib39">Lennox et al., 2020</xref>). Thus, diverse <italic>DDX3X</italic> mutations may result in divergent molecular and cellular pathologies and our study provides an important foundation upon which future investigations of <italic>DDX3X</italic> mutations may be compared.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"><italic>Ddx3x</italic></td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">MGI:103064; NCBI Gene: 13,205</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Ddx3y</italic></td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">MGI:1349406; NCBI Gene: 26,900</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Rcor2</italic></td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">MGI:1859854; NCBI Gene: 104,383</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Setd3</italic></td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">MGI:1289184; NCBI Gene: 52,690</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Topbp1</italic></td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">MGI:1920018; NCBI Gene: 235,559</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">C57BL/6 J</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">JAX #000664; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:000664">IMSR_JAX:000664</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Emx1</italic>-Cre</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">JAX #005628; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:005628">IMSR_JAX:005628</ext-link>; MGI:2684610</td><td align="left" valign="bottom">MGI symbol: Emx1 tm1(cre)Krj</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Rosa26<sup>Ai14</sup></italic></td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">JAX #007914; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:007914">IMSR_JAX:007914</ext-link></td><td align="left" valign="bottom">MGI symbol: Gt(ROSA)26Sor tm14(CAG-tdTomato)Hze</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Neurod6-Cre (NEX</italic>-Cre)</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/17146780/">17146780</ext-link></td><td align="left" valign="bottom">MGI:2668659</td><td align="left" valign="bottom">MGI symbol: Neurod6 tm1(cre)Kan</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Ddx3x<sup>lox/lox</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27179789/">27179789</ext-link></td><td align="left" valign="bottom">MGI:5774968</td><td align="left" valign="bottom">MGI symbol: Ddx3x tm1.1Lyou</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Ddx3y</italic> sgRNAs</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom">NCBI gene: 26,900</td><td align="left" valign="bottom">generated with Benchling for depleting <italic>Ddx3y</italic>; see <xref ref-type="fig" rid="fig2">Figure 2</xref></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">smFISH probes for <italic>Ddx3x</italic></td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom">NCBI gene: 13,205</td><td align="left" valign="bottom">generated with script from <xref ref-type="bibr" rid="bib65">Tsanov et al., 2016</xref> for monitoring <italic>Ddx3x</italic> RNA; see <xref ref-type="fig" rid="fig1">Figure 1</xref></td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">Scrambled siRNAs</td><td align="left" valign="bottom">Qiagen</td><td align="left" valign="bottom">Qiagen:1022076</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Setd3</italic> siRNAS</td><td align="left" valign="bottom">Qiagen</td><td align="left" valign="bottom">Qiagen:1027416</td><td align="left" valign="bottom">Gene ID: 52,690</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>M. musculus</italic>, male)</td><td align="left" valign="bottom">Neuro-2a</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">ATCC:CCL-131; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0470">CVCL_0470</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background</td><td align="left" valign="bottom">NEB 5-alpha Competent <italic>E. coli</italic> (High Efficiency)</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">NEB:C2987H</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Rcor2</italic> qPCR primers</td><td align="left" valign="bottom">Harvard PrimerBank; PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22086960/">22086960</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Harvard PrimerBank ID: 154147710 c2; Forward 5'-TGCTTCTGTGGCATAAACACG-3'; Reverse 5'-GGCTGGGAATCACCTTGTCAG-3'</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Setd3</italic> qPCR primers</td><td align="left" valign="bottom">Harvard PrimerBank; PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22086960/">22086960</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Harvard PrimerBank ID: 21312266a1; Forward 5'-AAATCAGGTACTGGGGCTACA-3'; Reverse 5'-GGCCCATTTCATTAGATCAGGGA-3'</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Topbp1</italic> qPCR primers</td><td align="left" valign="bottom">Harvard PrimerBank; PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22086960/">22086960</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">Harvard PrimerBank ID: 118130322 c1; Forward 5'-CAGGATTGTTGGTCCTCAAGTG-3'; Reverse 5'-ACAGGATACAGTTACGTCAGACA-3'</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-SOX2 (rat monoclonal)</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">ThermoFisher:14-9811-82; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11219471">AB_11219471</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-BrdU (rat monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Abcam:ab6326</td><td align="char" char="." valign="bottom">(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-TUJ1 (mouse monoclonal)</td><td align="left" valign="bottom">Biolegend</td><td align="left" valign="bottom">Biolegend:801202; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10063408">AB_10063408</ext-link></td><td align="char" char="." valign="bottom">(1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-CTIP2 (rat monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Abcam:AB18465</td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-TBR2 (rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Abcam:AB23345; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_778267">AB_778267</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-CC3 (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling</td><td align="left" valign="bottom">Cell Signaling:9661; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2341188">AB_2341188</ext-link></td><td align="char" char="." valign="bottom">(1:250)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-NEUROD2 (rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Abcam:AB104430; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10975628">AB_10975628</ext-link></td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-Ki67 (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cell Signaling:12,202</td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-PH3 (rabbit polyclonal)</td><td align="left" valign="bottom">Millipore</td><td align="left" valign="bottom">Millipore:06–570</td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-TBR1 (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cell Signaling Technology:49,661 S</td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-DDX3X (rabbit polyclonal)</td><td align="left" valign="bottom">Sigma Aldrich</td><td align="left" valign="bottom">Sigma Aldrich:HPA001648; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1078635">AB_1078635</ext-link></td><td align="left" valign="bottom">(IF, 1:500; western, 1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GFP (chicken polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Abcam:Ab13970; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_300798">AB_300798</ext-link></td><td align="char" char="." valign="bottom">(1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-B-actin (mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">Santa Cruz:sc-47778</td><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-mouse HRP (goat polyclonal)</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">ThermoFisher:32430; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1185566">AB_1185566</ext-link></td><td align="char" char="." valign="bottom">(1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-rabbit HRP (goat polyclonal)</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">ThermoFisher:A16110; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534782">AB_2534782</ext-link></td><td align="char" char="." valign="bottom">(1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-GFP (mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">Santa Cruz:sc9996</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">AlexaFluor-conjugated secondary antibodies (488, 555, 568, 594, 647)</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">(1:500)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pX330-U6-Chimeric_BB-CBh-hSpCas9</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">AddGene:42230; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_42230">Addgene_42230</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pX330-U6-Chimeric_BB-CBh-hSpCas9+<italic>Ddx3</italic>y guides</td><td align="left" valign="bottom">this paper</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Cloned for depletion of <italic>Ddx3y</italic>; see <xref ref-type="fig" rid="fig2">Figure 2</xref></td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pCAG-GFP</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32135084/">32135084</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pCAG-GFP-human DDX3X</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32135084/">32135084</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Click-it EdU AlexaFluor 594 imaging kit</td><td align="left" valign="bottom">Life Technologies</td><td align="left" valign="bottom">Life Technologies:c10339</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Qiagen RNAeasy kit</td><td align="left" valign="bottom">Qiagen</td><td align="left" valign="bottom">Qiagen:74,034</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Qiagen miRNA library prep kit</td><td align="left" valign="bottom">Qiagen</td><td align="left" valign="bottom">Qiagen:331,502</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RiboMinus Eukaryote kit v2</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">ThermoFisher:A15020</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNA Analysis Kit (15 nt)</td><td align="left" valign="bottom">Agilent</td><td align="left" valign="bottom">Agilent:DNF-471</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Kapa mRNA HyperPrep kit with mRNA capture</td><td align="left" valign="bottom">KapaBiosystems</td><td align="left" valign="bottom">KapaBiosystems:KR1352</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">iScript cDNA synthesis kit</td><td align="left" valign="bottom">BioRad</td><td align="left" valign="bottom">BioRad:1708891</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">iTaq Universal Sybr Green Supermix</td><td align="left" valign="bottom">BioRad</td><td align="left" valign="bottom">BioRad:1725121</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">BCA protein quantification</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">ThermoFisher:23,227</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">ECL</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">ThermoFisher:32,106</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">EdU</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">ThermoFisher:A10044</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">BrdU</td><td align="left" valign="bottom">Sigma Aldrich</td><td align="left" valign="bottom">Sigma:B5002</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Cycloheximide</td><td align="left" valign="bottom">Calbiochem</td><td align="left" valign="bottom">Sigma:239,764</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Fiji/ImageJ</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22743772/">22743772</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">v1.52i</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">QuPATH</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29203879/">29203879</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">v0.3.2</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">bowtie2</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22388286/">22388286</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">v2.4.4</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">STAR</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/23104886/">23104886</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">v2.7.9a</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">RibosomeProfilingQC</td><td align="left" valign="bottom">DOI:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18129/B9.bioc.ribosomeProfilingQC">10.18129/B9.bioc.ribosomeProfilingQC</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">v1.8.0</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Ribo-seQC</td><td align="left" valign="bottom">DOI:<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/601468">10.1101/601468</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">v0.99</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">DESeq2</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25516281/">25516281</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">v1.34.0</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ORFquant</td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33765284/">33765284</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">v1.02</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R</td><td align="left" valign="bottom">R Foundation for Statistical Computing</td><td align="left" valign="bottom"/><td align="left" valign="bottom">v4.1.0</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Vectashield</td><td align="left" valign="bottom">Vector Labs</td><td align="left" valign="bottom">Vector Labs:H-1000–10</td><td align="left" valign="bottom">See immunoflourescence section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">DAPI stain</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">ThermoFisher:D1306</td><td align="left" valign="bottom">See FACS section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Propidium iodide stain</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">ThermoFisher:P3566</td><td align="left" valign="bottom">See FACS section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Hoechst stain</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">ThermoFisher:H3570</td><td align="left" valign="bottom">See immunoflourescence section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Turbo DNase I</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Invitrogen:AM2238</td><td align="left" valign="bottom">See RNAseq and ribosome footprinting section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Superase In</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Invitrogen:AM2694</td><td align="left" valign="bottom">See RNAseq and ribosome footprinting section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">TRIzol</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Invitrogen:15596026</td><td align="left" valign="bottom">See RNAseq and ribosome footprinting section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">GlycoBlue</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Invitrogen: AM9515</td><td align="left" valign="bottom">See RNAseq and ribosome footprinting section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">PNK enzyme</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">NEB:M0247S</td><td align="left" valign="bottom">See RNAseq and ribosome footprinting section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">15% acrylamide denaturing urea-gel</td><td align="left" valign="bottom">BioRad</td><td align="left" valign="bottom">BioRad:4566053</td><td align="left" valign="bottom">See RNAseq and ribosome footprinting section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">2 X sample dye</td><td align="left" valign="bottom">Novex</td><td align="left" valign="bottom">Novex:LC6876</td><td align="left" valign="bottom">See RNAseq and ribosome footprinting section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">dsDNA ladder</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">ThermoFisher:10488023</td><td align="left" valign="bottom">See RNAseq and ribosome footprinting section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">miRNA ladders</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">NEB:N2102S</td><td align="left" valign="bottom">See RNAseq and ribosome footprinting section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">SYBR gold</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Invitrogen:S11494</td><td align="left" valign="bottom">See RNAseq and ribosome footprinting section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">SpinX column</td><td align="left" valign="bottom">Corning</td><td align="left" valign="bottom">Corning:CLS8162</td><td align="left" valign="bottom">See RNAseq and ribosome footprinting section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">TRIzol LS reagent</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">ThermoFisher:10296010</td><td align="left" valign="bottom">See RNA Immunoprecipitation section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Lipofectamine 2000</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">ThermoFisher:11668019</td><td align="left" valign="bottom">See RNA Immunoprecipitation section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Protein G-coated Dynabeads</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">ThermoFisher:0003D</td><td align="left" valign="bottom">See RNA Immunoprecipitation section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">GoTaq Green Master Mix</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Promega:M712</td><td align="left" valign="bottom">See RNA Immunoprecipitation section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">1 X RIPA buffer</td><td align="left" valign="bottom">Pierce</td><td align="left" valign="bottom">Pierce:89,900</td><td align="left" valign="bottom">See SDS-PAGE and western blot analysis section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">2 X sample buffer</td><td align="left" valign="bottom">BioRad</td><td align="left" valign="bottom">BioRad:1610737</td><td align="left" valign="bottom">See SDS-PAGE and western blot analysis section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">protease inhibitors</td><td align="left" valign="bottom">Sigma Aldrich</td><td align="left" valign="bottom">Sigma:78,429</td><td align="left" valign="bottom">See SDS-PAGE and western blot anlaysis section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">12% polyacrylamide gel</td><td align="left" valign="bottom">BioRad</td><td align="left" valign="bottom">BioRad:4568046</td><td align="left" valign="bottom">See SDS-PAGE and western blot anlaysis section in methods</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">PVDF membrane</td><td align="left" valign="bottom">BioRad</td><td align="left" valign="bottom">Biorad:1704157</td><td align="left" valign="bottom">See SDS-PAGE and western blot anlaysis section in methods</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mouse husbandry</title><p>All animal use was approved by the Duke Division of Laboratory Animal Resources and the Institutional Animal Care and Use Committee. The following lines were used and genotyped as described, all on C57BL/6 J background: <italic>Emx1</italic>-Cre (005628) (<xref ref-type="bibr" rid="bib18">Gorski et al., 2002</xref>) and <italic>Rosa26<sup>Ai14</sup></italic> (007914) (<xref ref-type="bibr" rid="bib43">Madisen et al., 2010</xref>) (Jackson Laboratory); <italic>Neurod6</italic>-Cre (<italic>Nex</italic>-Cre) (<xref ref-type="bibr" rid="bib17">Goebbels et al., 2006</xref>) (gift, Klaus-Nave); <italic>Ddx3x<sup>lox/lox</sup></italic> (<xref ref-type="bibr" rid="bib10">Chen et al., 2016a</xref>) (gift, Li-Ru You). Plug dates were defined as E0.5 on the morning the plug was identified.</p></sec><sec id="s4-2"><title>Statistical methods and rigor</title><p>Exact statistical tests, p-values, and n for each analysis are reported in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. For each experiment, both male and female mice were used and littermates were used when possible. All analyses were performed by 1 or more blinded investigators.</p></sec><sec id="s4-3"><title>Primary cultures and live imaging</title><p>Primary cortical cultures were derived from E14.5 embryonic dorsal cortices, as described (<xref ref-type="bibr" rid="bib45">Mitchell-Dick et al., 2019</xref>), but with minor modifications: (1) cortices were trypsinized for 6 min and (2) 150,000 cells were plated on poly-D-lysine-coated glass-bottom 24-well culture plates (MatTek). Images were captured every 10 min and mitosis duration and cell division were identified as previously (<xref ref-type="bibr" rid="bib51">Pilaz et al., 2016</xref>). Fate determination was performed post-imaging by immunostaining for Tuj1, Sox2, and Tbr2, as described (<xref ref-type="bibr" rid="bib45">Mitchell-Dick et al., 2019</xref>).</p></sec><sec id="s4-4"><title>Plasmids, subcloning, and qRT-PCR analysis</title><p><italic>Ddx3y</italic> sgRNAs were designed using Benchling and cloned into the pX330-U6-Chimeric_BB-CBh-hSpCas9 plasmid (AddGene # 42230) as described (<ext-link ext-link-type="uri" xlink:href="http://www.addgene.org/crispr/zhang/">http://www.addgene.org/crispr/zhang/</ext-link>). cDNA synthesis and qPCR were performed using the iScript Reverse Transcriptase and the iTaq Universal SYBR Green supermix (BioRad), respectively, per manufacturer’s instructions. The primers for qRT-PCR all had an annealing temperature of 60 °C and relative expression was normalized to β-actin. See <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref> for sgRNAs and primers.</p><sec id="s4-4-1"><title>Immunofluorescence</title><p>Embryonic brains were fixed and sectioned as previously (<xref ref-type="bibr" rid="bib44">Mao et al., 2015</xref>). Coronal 20 μm sections from the somatosensory cortex were permeabilized with 1 X PBS/0.25% TritonX-100 and blocked with 5% NGS/PBS for 1 hr at room temperature. Sections were incubated with primary antibodies overnight at 4 °C, and secondary antibodies at room temperature for 1 hr (Alexa Fluor-conjugated, Thermo Fisher, 1:500). EdU staining was performed as previously (<xref ref-type="bibr" rid="bib45">Mitchell-Dick et al., 2019</xref>). The following primary antibodies were used, <underline>rat:</underline> anti-SOX2 (Thermo Fisher, 14-9811-82, 1:1000), anti-BrdU (Abcam, ab6326, 1:200); <underline>mouse:</underline> anti-TUJ1 (Biolegend, 801202, 1:2000), anti-CTIP2 (Abcam, c8035, 1:500); <underline>rabbit:</underline> anti-TBR2 (Abcam, AB23345, 1:1000), anti-CC3 (Cell Signaling, 9661, 1:250), anti-NEUROD2 (Abcam, AB104430, 1:500), anti-Ki67 (Cell Signaling Technology, 12202, 1:1000), anti-PH3 (Millipore, 06–570, 1:500), anti-TBR1 (Cell Signaling Technology, 49,661 S, 1:1000), anti-Lhx2 (Millipore, ABE1402, 1:500), anti-DDX3X (Sigma Aldrich, HPA001648, 1:500); chicken anti-GFP (Abcam, Ab13970, 1:1000). Slides were mounted with Vectashield (Vector Labs, H-1000–10).</p></sec></sec><sec id="s4-5"><title>Imaging and analysis</title><p>Images were captured using a Zeiss Axio Observer Z.1 equipped with an Apotome for optical sectioning at 10X, 20X, and/or 63X. For each experiment, 2–3 sections were imaged/embryo; images were captured with identical exposures, cropped (200 or 300 μm radial columns), and brightness was equivalently adjusted across all images in Fiji. Cells were either manually (Fiji cell counter) or automatically (QuPath) counted. For QuPath, the following parameters were adjusted: requested pixel size = 0.1 µm, background radius = 5 µm, minimum area = 10 µm<sup>2</sup>, maximum area = 200 µm<sup>2</sup>, cell expansion = 2 µm, include cell nucleus and smooth boundaries were unchecked. The threshold was set for each individual channel, but equivalently across all sections (generally between 25 and 100). For binning analysis, 200 or 300 μm wide radial columns were divided into 5 or 10 evenly spaced bins spanning from the ventricular (bin 1) to the pial (bin 5 or 10) surface. Each cell was assigned to a bin to calculate the distribution.</p><sec id="s4-5-1"><title><italic>In utero</italic> electroporation</title><p>Plasmids were delivered to embryonic brains and IUEs were performed as previously (<xref ref-type="bibr" rid="bib39">Lennox et al., 2020</xref>). Plasmids were used at the following concentrations: pCAG-GFP (1.0 μg/μL), pX330 empty or pX330-<italic>Ddx3y</italic> Ex2 sgRNA (2.4 μg/μL). Scrambled (Qiagen, 1022076) or <italic>Setd3</italic> siRNAs (Qiagen 1027416, Gene ID: 52690) were injected at 2.5 μM.</p></sec><sec id="s4-5-2"><title>EdU and BrdU injections</title><p>For cell cycle exit, EdU was administered by IP injection at 10 mg/kg to pregnant dams at E13.5 and embryos were harvested exactly 24 hr later. For semi-cumulative labeling, EdU was administered by IP injection at 10 mg/kg at t=0 followed by BrdU (30 mg/kg) at t=1.5 hr. The following calculations were used to derive Tc and Ts: S cells = BrdU + ; P cells = Ki67+; L cell fraction = EdU + BrdU- (ie: EdU +minus BrdU+); Ts=(S cells/L cells) * 1.5; Tc=(P cells/S cells) *Ts.</p><p>Single molecule fluorescence <italic>in situ</italic> hybridization (smFISH) smFISH probes against <italic>Mus musculus Ddx3x</italic> were designed and prepared as described (<xref ref-type="bibr" rid="bib65">Tsanov et al., 2016</xref>). All solutions and buffers were prepared with diethyl pyrocarbonate, including PFA and sucrose, to quench RNAse activity. Twenty µm coronal sections were permeabilized in 0.5% Triton X-100 in PBS for 30 min at room temperature and rinsed twice with buffer containing 10% formamide and 2 x SCC buffer (Thermo, 15557044). smFISH probes were diluted 1:200 in buffer containing 10% formamide, 2 x SCC buffer and 10% dextran sulfate; 200 µL of diluted probes were added to each slide and incubated overnight at 37 °C. The next day, samples were washed two times at 37 °C and Hoechst was included in second wash. Slides were mounted with Vectashield (Vector Labs, H-1000–10). Slides were imaged at 63X. Puncta were counted in QuPath (<xref ref-type="bibr" rid="bib2">Bankhead et al., 2017</xref>) in a 75 µm<sup>2</sup> box in the ventricular zone using a detection threshold of 0.2 and an expected detection size of 0.5 µm with the minimum being 0.4 and the maximum being 2.</p></sec></sec><sec id="s4-6"><title>FACS</title><p>Samples were processed for FACS as described (<xref ref-type="bibr" rid="bib45">Mitchell-Dick et al., 2019</xref>) and sorted at 6 °C using a B-C Astrios cell sorter with gates for forward scatter (FSC), side scatter (SSC), DAPI or Propidium Iodide (PI), GFP or TdTomato, and were sorted directly into RLT buffer and RNA was extracted (Qiagen RNAeasy kit; Qiagen, 74034).</p><sec id="s4-6-1"><title>RNAseq and ribosome footprinting</title><p>Embryonic cortices were flash-frozen in liquid nitrogen and stored at –80 °C. For each n, four E11.5 microdissected cortices were thawed on ice and lysed in 400 μL of polysome buffer (20 mM Tris-HCl) pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, 100 μg/ml cycloheximide (CHX; Calbiochem, CAS 66-81-9), 25 U/ml Turbo DNase I (Invitrogen, AM2238) using a hand-blender. Lysates were pelleted at 2000 g for 10 min and titurated with a 26-gauge needle before adding TritonX-100% to 1%. Lysates were then clarified at 20,000 g for 10 min. A total of 100 μL of lysate was taken for RNA, to which 300 μL of RLT buffer was added and RNA was extracted using the RNAeasy kit (Qiagen, 74034). The remaining lysate was treated with 1 μL of RNase I (Ambion, AM2294) and incubated for 30 min at RT. After nuclease digestion, 1 μL of Superase In (Invitrogen, AM2694) was added, followed by 1 ml of TRIzol (Invitrogen, 15596026) and 200 μL of chloroform. The samples were vigorously shaken for 30 s and incubated for 3 min at RT before centrifugation at 12,000 g for 10 min at 4 °C. Approximately 750 μL of supernatant was mixed with 750 μL of isopropanol, 2 μL of glycoblue (Invitrogen AM9515), and 30 μL of sodium acetate (NaOAc) and frozen at –20 °C overnight. The next day, samples were spun (20,000 g, 15 mins, 4 °C) and the pellet was washed 2 X with 80% ethanol and allowed to air-dry before resuspending the pellet in 7 μL of RNase-free water. A PNK reaction was then performed at 37 °C for 30 min on digested RNA by adding 1 μL of PNK buffer, 1 μL of 100 mM ATP, and 1 μL of PNK enzyme (NEB, M0247S). During the incubation, a 15% acrylamide denaturing urea-gel (Biorad, 4566053) was pre-run (200 V, 15 min, 1 X TBE buffer). Samples (containing 2 X sample dye Novex, LC6876) were run (~45 min, 200 V), along with dsDNA (Thermo, 10488023) and miRNA ladders (NEB, N2102S). Afterwards, the gel was incubated with SYBR gold (Invitrogen S11494) for 5 min and the RPFs (~25–30 nt) were isolated and frozen in 400 mM NaOAc at –80 °C. The following day, frozen gel fragments were thawed (95 °C, 5 min) and vortexed (20 min, 3 X). The supernatant was spun through a SpinX column (Corning, CLS8162) (max speed,10 mins) and 500 μL isopropanol and 2 μL glycoblue were added before freezing (–20 °C, 1 hr). The samples were centrifuged (max speed, 15 min, 4 °C) and washed 2 X with 80% EtOH. The pellet was resuspended in 5 μL of water and libraries were prepared using the Qiagen miRNA library prep kit (331502; followed protocol for 100 ng input and did 15 cycles of PCR amplification). Ribosomal RNA depletion was performed after the 3′ adapter ligation step using the RiboMinus Eukaryote kit v2 (Thermo Fisher, A15020). For RNAseq cDNA library preparation, RNA concentrations were measured using a NanoDrop spectrophotometer (Thermo Scientific) and the quality of RNA was assessed using an Agilent fragment analyzer and the RNA Analysis Kit (15 nt; Agilent, DNF-471). cDNA libraries were generated using the Kapa mRNA HyperPrep kit with mRNA capture (KapaBiosystems, KR1352) using 50 ng input RNA.</p></sec><sec id="s4-6-2"><title>Sequencing and bioinformatic analysis</title><p>Three samples per condition per sex (WT and cKO) were sequenced, but one WT F had to be removed due to inefficient library prep. RNAseq and Ribo-seq libraries were sequenced on the NovaSeq 6,000 S-Prime with 150 bp paired-end reads and 75 bp single end reads, respectively. For RNAseq, libraries were sequenced to a depth of ~40–60 million total reads per sample. For Ribo-seq, libraries were sequenced to a depth of 50–70 million reads and only reads that uniquely mapped were retained. After adapter removal, reads were mapped to rRNA (<xref ref-type="bibr" rid="bib37">Langmead and Salzberg, 2012</xref>) using bowtie2 v2.4.4, the remaining reads were mapped to GENCODE22 using STAR v2.7.9a (<xref ref-type="bibr" rid="bib14">Dobin et al., 2013</xref>). Quality control of mapped reads and count matrices, using uniquely mapping reads only, were obtained using RibosomeProfilingQC (<xref ref-type="bibr" rid="bib25">Jianghong Ou, 2021</xref>) and Ribo-seQC (<xref ref-type="bibr" rid="bib7">Calviello et al., 2019</xref>). Changes in TE were calculated using DESeq2 by using assay type (RNA-seq or Ribo-seq) as an additional covariate. Translationally regulated genes were defined using an FDR &lt;0.05 from a likelihood ratio test, using a reduced model without the assay type covariate, for example assuming no difference between RNA-seq and Ribo-seq counts (<xref ref-type="bibr" rid="bib9">Calviello et al., 2021</xref>). ORFquant (<xref ref-type="bibr" rid="bib8">Calviello et al., 2020</xref>) v1.02 was used to <italic>de novo</italic> identify translated ORFs using the pooled Ribo-seq data and Gencode M22 annotation as reference. Inputs to ORFquant were obtained using RiboseQC (<xref ref-type="bibr" rid="bib7">Calviello et al., 2019</xref>). Only ATG-starting ORFs were detected using uniquely mapping reads only.</p></sec><sec id="s4-6-3"><title>Polysome profiling</title><p>Embryonic cortices were dissected and lysed identically to those used for Ribo-seq. Cortices from 2 embryos were pooled per n. Following clarification at 20,000 g, 50 μL of lysate was taken for RNA input. Clarified lysates were added to prepared 15–50% sucrose gradients (in the lysis buffer above, except lacking CHX and DNase) and ultracentrifuged (35,000 X g, 2 or 3.5 hr, 4 °C) using a SW41 Ti rotor. Following ultracentrifugation, 12 fractions (~1 ml each) were collected from each sample using a BioComp Piston Gradient Fractionator instrument fitted with a TRIAX flow cell to measure absorbance. RNA was extracted from 300 μL of each fraction or pooled fractions using TRIzol LS reagent (Thermo Fisher, 10296010). cDNA was synthesized from 250 ng of RNA using the iScript cDNA synthesis kit (Bio-Rad) (40 min, 46 °C), followed by RT-qPCR using gene-specific primers. Gene expression across different fractions was normalized to <italic>B-actin</italic> and then set relative to the corresponding expression from input.</p></sec><sec id="s4-6-4"><title>RNA immunoprecipitation (RIP)</title><p>Neuro2A cells were seeded into a six-well plate and transfected at confluency with Lipofectamine 2000 (ThermoFisher, 11668019) alone or with pCAG-GFP-human DDX3X per manufacturer protocol; after 4 hr, transfection media was exchanged for fresh media. At 24 hr post-transfection, cells were subjected to RNA immunoprecipitation as previously (<xref ref-type="bibr" rid="bib31">Keene et al., 2006</xref>) with modifications as listed here. Cells were scraped from the plate surface, washed twice in cold PBS, and lysed via trituration with a p200 pipette in 100 µL of lysis buffer (10 mM HEPES pH 7, 100 mM KCl, 5 mM MgCl2, 1 mM DTT, 0.5% NP-40). Following a 5-min centrifugation at 6500 g at 4 °C, 50 μL of supernatant was transferred to each of two tubes for immunoprecipitation, with the remaining ~10 µl of supernatant kept as input. A total of 193 µl of ice-cold NT2 buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM MgCl2, 0.05% NP-40) supplemented with 1 μL RNaseOUT (Invitrogen, 10777019) was added to the immunoprecipitation tubes together with 3.4 µg of anti-GFP (Santa Cruz, sc9996). This mix was incubated overnight at 4 °C with rotation. Fifty µl of magnetic beads solution (Protein G-coated Dynabeads, ThermoFisher Scientific, 0003D) were washed with 1 mL NT2 for each immunoprecipitation condition. Lysates were subsequently added to the washed beads and incubated for 4 hr at 4 °C with rotation. Beads were then washed five times with 1 mL NT2 buffer per wash. To prepare RNA for PCR analysis, 1 mL of TRIzol (ThermoFisher Scientific) was added to the beads and RNA was purified per the manufacturer’s instructions. cDNA was prepared from 250 ng of RNA per condition using the iScript cDNA synthesis kit (Bio-Rad) according to the manufacturer’s instructions. Resulting cDNAs were diluted 1:5, and 1 µL of this dilution was used as a PCR template for amplification using GoTaq Green Master Mix (Promega). Products were run on a 2% agarose gel and imaged using a BioRad GelDoc system.</p></sec><sec id="s4-6-5"><title>Cell lines</title><p>Neuro2A cells were obtained from ATCC, and their identity was authenticated based on imaging for morphology and qPCR analyses of mouse genes. Freshly purchased vials are used for these experiments. These cells were only used for transfection of siRNAs or constructs and confirmation of knockdown and expression. No cellular phenotypic assays were performed with these cells.</p></sec><sec id="s4-6-6"><title>SDS-PAGE and western blot analysis</title><p>The dorsal telencephalon of cortices from E14.5 mice were micro-dissected and flash frozen in liquid nitrogen and stored at –80 °C. Samples were lysed in 1 X RIPA buffer (Pierce, 89900) supplemented with protease inhibitors (Sigma, 78429) and titurated with a p1000 pipette and then spun at 15,000 g for 5 min at +4 °C. A BCA protein quantification was performed (Thermo, 23227) and 15 µg of protein was mixed with 2 X sample buffer (Biorad, 1610737) and heated at 95 °C for 10 min. Fifteen µL of sample was separated on a 12% polyacrylamide gel (Biorad, 4568046). The gel was transferred to a PVDF membrane (Biorad, 1704157) using the Trans-Blot Turbo system (Biorad). The membrane was then blocked in 5% milk/PBS-T for 1 hr at room temperature and then incubated overnight with anti-DDX3X (Sigma, HPA001648, 1:1000) and anti-B-actin (Santa Cruz, sc-47778, 1:500) in 5% milk/PBS-T at +4 °C. The membranes were washed 5 X with 1 X PBS-T and then incubated with anti-mouse and anti-rabbit HRP (Thermo, 32,430 and A16110, 1:2000) for 1 hr at room temperature in 5% milk/PBS-T. The membranes were again washed with 1 X PBS-T and then exposed using ECL (Thermo, 32106) and imaged on a ChemiDoc XRS+ (Biorad). Densitometry analysis was performed as previously described.</p></sec></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Validation, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Software, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Formal analysis, Software, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Funding acquisition, Methodology, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – original draft, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal use was approved by the Duke Institutional Animal Care and Use Committee (IACUC # A060-22-03) through 4/1/25. A statement was included in the manuscript.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>An excel file containing the comparison, sample size, statistical test and number of litters used (when applicable) for each data plot.</title></caption><media xlink:href="elife-78203-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>An excel file containing the primer and sgRNA sequences used in this paper.</title></caption><media xlink:href="elife-78203-supp2-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>An excel file containing three tabs (1) the differential expression analysis of controls versus Ddx3x cKO for RNAseq and Riboseq data (using only unique reads); (2) the analysis of translational efficiency from wildtype (ie: control) data (using all reads); (3) the cell type-enriched transcripts used in <xref ref-type="fig" rid="fig6">Figure 6B</xref>.</title></caption><media xlink:href="elife-78203-supp3-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-78203-transrepform1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Sequencing data has been deposited at GEO with the following accession number: GSE203078 . Supplemental excels for the sequencing data have been provided (Supplemental Excel 3).</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Hoye</surname><given-names>ML</given-names></name><name><surname>Calviello</surname><given-names>L</given-names></name><name><surname>Poff</surname><given-names>AJ</given-names></name><name><surname>Ejimogu</surname><given-names>NE</given-names></name><name><surname>Newman</surname><given-names>CR</given-names></name><name><surname>Montgomery</surname><given-names>MD</given-names></name><name><surname>Ou</surname><given-names>J</given-names></name><name><surname>Floor</surname><given-names>SN</given-names></name><name><surname>Silver</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Data from: Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE203078">GSE203078</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank the <italic>DDX3X</italic> Foundation and members of the Silver, Floor, and Sherr labs for helpful discussions. This work was supported by the Holland-Trice Foundation, the DDX3X Foundation (DLS), NIH R21ND104514 (DLS), NIH R01NS120667 (DLS, SNF); Regeneration Next Initiative Postdoctoral Fellowship, NIH F32NS112566 (MLH); National Institutes of Health DP2GM132932 (SNF). S.N.F. is a Pew Scholar in the Biomedical Sciences, supported by The Pew Charitable Trusts. We thank Chris Nicchitta for help with Ribo-seq and Stacy Horner for use of the polysome profiling equipment. We thank Klaus-Nave (<italic>Neurod6</italic>-Cre/<italic>Nex</italic>-Cre) and Li-Ru You (<italic>Ddx3x<sup>lox/lox</sup></italic>) for mice. We thank the Duke Flow Cytometry and Genomics cores.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arai</surname><given-names>Y</given-names></name><name><surname>Pulvers</surname><given-names>JN</given-names></name><name><surname>Haffner</surname><given-names>C</given-names></name><name><surname>Schilling</surname><given-names>B</given-names></name><name><surname>Nüsslein</surname><given-names>I</given-names></name><name><surname>Calegari</surname><given-names>F</given-names></name><name><surname>Huttner</surname><given-names>WB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neural stem and progenitor cells shorten S-phase on commitment to neuron production</article-title><source>Nature Communications</source><volume>2</volume><elocation-id>154</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms1155</pub-id><pub-id pub-id-type="pmid">21224845</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bankhead</surname><given-names>P</given-names></name><name><surname>Loughrey</surname><given-names>MB</given-names></name><name><surname>Fernández</surname><given-names>JA</given-names></name><name><surname>Dombrowski</surname><given-names>Y</given-names></name><name><surname>McArt</surname><given-names>DG</given-names></name><name><surname>Dunne</surname><given-names>PD</given-names></name><name><surname>McQuaid</surname><given-names>S</given-names></name><name><surname>Gray</surname><given-names>RT</given-names></name><name><surname>Murray</surname><given-names>LJ</given-names></name><name><surname>Coleman</surname><given-names>HG</given-names></name><name><surname>James</surname><given-names>JA</given-names></name><name><surname>Salto-Tellez</surname><given-names>M</given-names></name><name><surname>Hamilton</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>QuPath: Open source software for digital pathology image analysis</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>16878</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-17204-5</pub-id><pub-id pub-id-type="pmid">29203879</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beal</surname><given-names>B</given-names></name><name><surname>Hayes</surname><given-names>I</given-names></name><name><surname>McGaughran</surname><given-names>J</given-names></name><name><surname>Amor</surname><given-names>DJ</given-names></name><name><surname>Miteff</surname><given-names>C</given-names></name><name><surname>Jackson</surname><given-names>V</given-names></name><name><surname>van Reyk</surname><given-names>O</given-names></name><name><surname>Subramanian</surname><given-names>G</given-names></name><name><surname>Hildebrand</surname><given-names>MS</given-names></name><name><surname>Morgan</surname><given-names>AT</given-names></name><name><surname>Goel</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Expansion of phenotype of DDX3X syndrome: six new cases</article-title><source>Clinical Dysmorphology</source><volume>28</volume><fpage>169</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1097/MCD.0000000000000289</pub-id><pub-id pub-id-type="pmid">31274575</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname><given-names>JD</given-names></name><name><surname>Hockemeyer</surname><given-names>D</given-names></name><name><surname>Doudna</surname><given-names>JA</given-names></name><name><surname>Bateup</surname><given-names>HS</given-names></name><name><surname>Floor</surname><given-names>SN</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Widespread Translational Remodeling during Human Neuronal Differentiation</article-title><source>Cell Reports</source><volume>21</volume><fpage>2005</fpage><lpage>2016</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.10.095</pub-id><pub-id pub-id-type="pmid">29141229</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boitnott</surname><given-names>A</given-names></name><name><surname>Garcia-Forn</surname><given-names>M</given-names></name><name><surname>Ung</surname><given-names>DC</given-names></name><name><surname>Niblo</surname><given-names>K</given-names></name><name><surname>Mendonca</surname><given-names>D</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name><name><surname>Flores</surname><given-names>M</given-names></name><name><surname>Maxwell</surname><given-names>S</given-names></name><name><surname>Ellegood</surname><given-names>J</given-names></name><name><surname>Qiu</surname><given-names>LR</given-names></name><name><surname>Grice</surname><given-names>DE</given-names></name><name><surname>Lerch</surname><given-names>JP</given-names></name><name><surname>Rasin</surname><given-names>MR</given-names></name><name><surname>Buxbaum</surname><given-names>JD</given-names></name><name><surname>Drapeau</surname><given-names>E</given-names></name><name><surname>De Rubeis</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Developmental and Behavioral Phenotypes in a Mouse Model of DDX3X Syndrome</article-title><source>Biological Psychiatry</source><volume>90</volume><fpage>742</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2021.05.027</pub-id><pub-id pub-id-type="pmid">34344536</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>JL</given-names></name><name><surname>Skove</surname><given-names>SL</given-names></name><name><surname>Rouanet</surname><given-names>JP</given-names></name><name><surname>Pilaz</surname><given-names>LJ</given-names></name><name><surname>Bepler</surname><given-names>T</given-names></name><name><surname>Gordân</surname><given-names>R</given-names></name><name><surname>Wray</surname><given-names>GA</given-names></name><name><surname>Silver</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Human-chimpanzee differences in a FZD8 enhancer alter cell-cycle dynamics in the developing neocortex</article-title><source>Current Biology</source><volume>25</volume><fpage>772</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2015.01.041</pub-id><pub-id pub-id-type="pmid">25702574</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Calviello</surname><given-names>L</given-names></name><name><surname>Sydow</surname><given-names>D</given-names></name><name><surname>Harnett</surname><given-names>D</given-names></name><name><surname>Ohler</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ribo-SeQC: Comprehensive Analysis of Cytoplasmic and Organellar Ribosome Profiling Data</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/601468</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calviello</surname><given-names>L</given-names></name><name><surname>Hirsekorn</surname><given-names>A</given-names></name><name><surname>Ohler</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Quantification of translation uncovers the functions of the alternative transcriptome</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>27</volume><fpage>717</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1038/s41594-020-0450-4</pub-id><pub-id pub-id-type="pmid">32601440</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calviello</surname><given-names>L</given-names></name><name><surname>Venkataramanan</surname><given-names>S</given-names></name><name><surname>Rogowski</surname><given-names>KJ</given-names></name><name><surname>Wyler</surname><given-names>E</given-names></name><name><surname>Wilkins</surname><given-names>K</given-names></name><name><surname>Tejura</surname><given-names>M</given-names></name><name><surname>Thai</surname><given-names>B</given-names></name><name><surname>Krol</surname><given-names>J</given-names></name><name><surname>Filipowicz</surname><given-names>W</given-names></name><name><surname>Landthaler</surname><given-names>M</given-names></name><name><surname>Floor</surname><given-names>SN</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>DDX3 depletion represses translation of mRNAs with complex 5’ UTRs</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>5336</fpage><lpage>5350</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab287</pub-id><pub-id pub-id-type="pmid">33905506</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CY</given-names></name><name><surname>Chan</surname><given-names>CH</given-names></name><name><surname>Chen</surname><given-names>CM</given-names></name><name><surname>Tsai</surname><given-names>YS</given-names></name><name><surname>Tsai</surname><given-names>TY</given-names></name><name><surname>Wu Lee</surname><given-names>YH</given-names></name><name><surname>You</surname><given-names>LR</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>Targeted inactivation of murine Ddx3x: essential roles of Ddx3x in placentation and embryogenesis</article-title><source>Human Molecular Genetics</source><volume>25</volume><fpage>2905</fpage><lpage>2922</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddw143</pub-id><pub-id pub-id-type="pmid">27179789</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>HH</given-names></name><name><surname>Yu</surname><given-names>HI</given-names></name><name><surname>Tarn</surname><given-names>WY</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>DDX3 Modulates Neurite Development via Translationally Activating an RNA Regulon Involved in Rac1 Activation</article-title><source>The Journal of Neuroscience</source><volume>36</volume><fpage>9792</fpage><lpage>9804</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4603-15.2016</pub-id><pub-id pub-id-type="pmid">27656019</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YC</given-names></name><name><surname>Chang</surname><given-names>YW</given-names></name><name><surname>Huang</surname><given-names>YS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dysregulated Translation in Neurodevelopmental Disorders: An Overview of Autism-Risk Genes Involved in Translation</article-title><source>Developmental Neurobiology</source><volume>79</volume><fpage>60</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1002/dneu.22653</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Bella</surname><given-names>DJ</given-names></name><name><surname>Habibi</surname><given-names>E</given-names></name><name><surname>Stickels</surname><given-names>RR</given-names></name><name><surname>Scalia</surname><given-names>G</given-names></name><name><surname>Brown</surname><given-names>J</given-names></name><name><surname>Yadollahpour</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>SM</given-names></name><name><surname>Abbate</surname><given-names>C</given-names></name><name><surname>Biancalani</surname><given-names>T</given-names></name><name><surname>Macosko</surname><given-names>EZ</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Molecular logic of cellular diversification in the mouse cerebral cortex</article-title><source>Nature</source><volume>595</volume><fpage>554</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03670-5</pub-id><pub-id pub-id-type="pmid">34163074</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Star: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elvira</surname><given-names>G</given-names></name><name><surname>Wasiak</surname><given-names>S</given-names></name><name><surname>Blandford</surname><given-names>V</given-names></name><name><surname>Tong</surname><given-names>X-K</given-names></name><name><surname>Serrano</surname><given-names>A</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>del Rayo Sánchez-Carbente</surname><given-names>M</given-names></name><name><surname>Servant</surname><given-names>F</given-names></name><name><surname>Bell</surname><given-names>AW</given-names></name><name><surname>Boismenu</surname><given-names>D</given-names></name><name><surname>Lacaille</surname><given-names>J-C</given-names></name><name><surname>McPherson</surname><given-names>PS</given-names></name><name><surname>DesGroseillers</surname><given-names>L</given-names></name><name><surname>Sossin</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Characterization of an RNA granule from developing brain</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>5</volume><fpage>635</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1074/mcp.M500255-MCP200</pub-id><pub-id pub-id-type="pmid">16352523</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farkas</surname><given-names>LM</given-names></name><name><surname>Haffner</surname><given-names>C</given-names></name><name><surname>Giger</surname><given-names>T</given-names></name><name><surname>Khaitovich</surname><given-names>P</given-names></name><name><surname>Nowick</surname><given-names>K</given-names></name><name><surname>Birchmeier</surname><given-names>C</given-names></name><name><surname>Pääbo</surname><given-names>S</given-names></name><name><surname>Huttner</surname><given-names>WB</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Insulinoma-associated 1 has a panneurogenic role and promotes the generation and expansion of basal progenitors in the developing mouse neocortex</article-title><source>Neuron</source><volume>60</volume><fpage>40</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2008.09.020</pub-id><pub-id pub-id-type="pmid">18940587</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goebbels</surname><given-names>S</given-names></name><name><surname>Bormuth</surname><given-names>I</given-names></name><name><surname>Bode</surname><given-names>U</given-names></name><name><surname>Hermanson</surname><given-names>O</given-names></name><name><surname>Schwab</surname><given-names>MH</given-names></name><name><surname>Nave</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Genetic targeting of principal neurons in neocortex and hippocampus of NEX-Cre mice</article-title><source>Genesis (New York, N.Y</source><volume>44</volume><fpage>611</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1002/dvg.20256</pub-id><pub-id pub-id-type="pmid">17146780</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorski</surname><given-names>JA</given-names></name><name><surname>Talley</surname><given-names>T</given-names></name><name><surname>Qiu</surname><given-names>M</given-names></name><name><surname>Puelles</surname><given-names>L</given-names></name><name><surname>Rubenstein</surname><given-names>JLR</given-names></name><name><surname>Jones</surname><given-names>KR</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage</article-title><source>The Journal of Neuroscience</source><volume>22</volume><fpage>6309</fpage><lpage>6314</lpage><pub-id pub-id-type="pmid">12151506</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grafodatskaya</surname><given-names>D</given-names></name><name><surname>Chung</surname><given-names>B</given-names></name><name><surname>Szatmari</surname><given-names>P</given-names></name><name><surname>Weksberg</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Autism spectrum disorders and epigenetics</article-title><source>Journal of the American Academy of Child and Adolescent Psychiatry</source><volume>49</volume><fpage>794</fpage><lpage>809</lpage><pub-id pub-id-type="doi">10.1016/j.jaac.2010.05.005</pub-id><pub-id pub-id-type="pmid">20643313</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Harnett</surname><given-names>D</given-names></name><name><surname>Ambrozkiewicz</surname><given-names>MC</given-names></name><name><surname>Zinnall</surname><given-names>U</given-names></name><name><surname>Rusanova</surname><given-names>A</given-names></name><name><surname>Borisova</surname><given-names>E</given-names></name><name><surname>Dannenberg</surname><given-names>R</given-names></name><name><surname>Imami</surname><given-names>K</given-names></name><name><surname>Münster-Wandowski</surname><given-names>A</given-names></name><name><surname>Fauler</surname><given-names>B</given-names></name><name><surname>Mielke</surname><given-names>T</given-names></name><name><surname>Selbach</surname><given-names>M</given-names></name><name><surname>Landthaler</surname><given-names>M</given-names></name><name><surname>Spahn</surname><given-names>CMT</given-names></name><name><surname>Tarabykin</surname><given-names>V</given-names></name><name><surname>Ohler</surname><given-names>U</given-names></name><name><surname>Kraushar</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A Critical Period of Translational Control during Brain Development at Codon Resolution</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2021.06.23.449626</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heerma van Voss</surname><given-names>MR</given-names></name><name><surname>Kammers</surname><given-names>K</given-names></name><name><surname>Vesuna</surname><given-names>F</given-names></name><name><surname>Brilliant</surname><given-names>J</given-names></name><name><surname>Bergman</surname><given-names>Y</given-names></name><name><surname>Tantravedi</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Cole</surname><given-names>RN</given-names></name><name><surname>Holland</surname><given-names>A</given-names></name><name><surname>van Diest</surname><given-names>PJ</given-names></name><name><surname>Raman</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach</article-title><source>Translational Oncology</source><volume>11</volume><fpage>755</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1016/j.tranon.2018.04.001</pub-id><pub-id pub-id-type="pmid">29684792</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoye</surname><given-names>ML</given-names></name><name><surname>Silver</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Decoding mixed messages in the developing cortex: translational regulation of neural progenitor fate</article-title><source>Current Opinion in Neurobiology</source><volume>66</volume><fpage>93</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2020.10.001</pub-id><pub-id pub-id-type="pmid">33130411</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingolia</surname><given-names>NT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ribosome Footprint Profiling of Translation throughout the Genome</article-title><source>Cell</source><volume>165</volume><fpage>22</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.02.066</pub-id><pub-id pub-id-type="pmid">27015305</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iossifov</surname><given-names>I</given-names></name><name><surname>O’Roak</surname><given-names>BJ</given-names></name><name><surname>Sanders</surname><given-names>SJ</given-names></name><name><surname>Ronemus</surname><given-names>M</given-names></name><name><surname>Krumm</surname><given-names>N</given-names></name><name><surname>Levy</surname><given-names>D</given-names></name><name><surname>Stessman</surname><given-names>HA</given-names></name><name><surname>Witherspoon</surname><given-names>KT</given-names></name><name><surname>Vives</surname><given-names>L</given-names></name><name><surname>Patterson</surname><given-names>KE</given-names></name><name><surname>Smith</surname><given-names>JD</given-names></name><name><surname>Paeper</surname><given-names>B</given-names></name><name><surname>Nickerson</surname><given-names>DA</given-names></name><name><surname>Dea</surname><given-names>J</given-names></name><name><surname>Dong</surname><given-names>S</given-names></name><name><surname>Gonzalez</surname><given-names>LE</given-names></name><name><surname>Mandell</surname><given-names>JD</given-names></name><name><surname>Mane</surname><given-names>SM</given-names></name><name><surname>Murtha</surname><given-names>MT</given-names></name><name><surname>Sullivan</surname><given-names>CA</given-names></name><name><surname>Walker</surname><given-names>MF</given-names></name><name><surname>Waqar</surname><given-names>Z</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Willsey</surname><given-names>AJ</given-names></name><name><surname>Yamrom</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Grabowska</surname><given-names>E</given-names></name><name><surname>Dalkic</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Marks</surname><given-names>S</given-names></name><name><surname>Andrews</surname><given-names>P</given-names></name><name><surname>Leotta</surname><given-names>A</given-names></name><name><surname>Kendall</surname><given-names>J</given-names></name><name><surname>Hakker</surname><given-names>I</given-names></name><name><surname>Rosenbaum</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>B</given-names></name><name><surname>Rodgers</surname><given-names>L</given-names></name><name><surname>Troge</surname><given-names>J</given-names></name><name><surname>Narzisi</surname><given-names>G</given-names></name><name><surname>Yoon</surname><given-names>S</given-names></name><name><surname>Schatz</surname><given-names>MC</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name><name><surname>McCombie</surname><given-names>WR</given-names></name><name><surname>Shendure</surname><given-names>J</given-names></name><name><surname>Eichler</surname><given-names>EE</given-names></name><name><surname>State</surname><given-names>MW</given-names></name><name><surname>Wigler</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The contribution of de novo coding mutations to autism spectrum disorder</article-title><source>Nature</source><volume>515</volume><fpage>216</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1038/nature13908</pub-id><pub-id pub-id-type="pmid">25363768</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Jianghong Ou</surname><given-names>MLH</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>ribosomeProfilingQC: Ribosome Profiling Quality Control</data-title><source>Bioconductor</source><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/ribosomeProfilingQC.html">https://bioconductor.org/packages/release/bioc/html/ribosomeProfilingQC.html</ext-link></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Simmons</surname><given-names>SK</given-names></name><name><surname>Guo</surname><given-names>A</given-names></name><name><surname>Shetty</surname><given-names>AS</given-names></name><name><surname>Ko</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>L</given-names></name><name><surname>Jokhi</surname><given-names>V</given-names></name><name><surname>Robinson</surname><given-names>E</given-names></name><name><surname>Oyler</surname><given-names>P</given-names></name><name><surname>Curry</surname><given-names>N</given-names></name><name><surname>Deangeli</surname><given-names>G</given-names></name><name><surname>Lodato</surname><given-names>S</given-names></name><name><surname>Levin</surname><given-names>JZ</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>In vivo Perturb-Seq reveals neuronal and glial abnormalities associated with autism risk genes</article-title><source>Science (New York, N.Y.)</source><volume>370</volume><elocation-id>6520</elocation-id><pub-id pub-id-type="doi">10.1126/science.aaz6063</pub-id><pub-id pub-id-type="pmid">33243861</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Johnson-Kerner</surname><given-names>B</given-names></name><name><surname>Snijders Blok</surname><given-names>L</given-names></name><name><surname>Suit</surname><given-names>L</given-names></name><name><surname>Thomas</surname><given-names>J</given-names></name><name><surname>Kleefstra</surname><given-names>T</given-names></name><name><surname>Sherr</surname><given-names>EH</given-names></name></person-group><year iso-8601-date="1993">1993</year><data-title>DDX3X-Related Neurodevelopmental Disorder</data-title><source>GeneReviews((R</source></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnstone</surname><given-names>TG</given-names></name><name><surname>Bazzini</surname><given-names>AA</given-names></name><name><surname>Giraldez</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Upstream ORFs are prevalent translational repressors in vertebrates</article-title><source>The EMBO Journal</source><volume>35</volume><fpage>706</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.15252/embj.201592759</pub-id><pub-id pub-id-type="pmid">26896445</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>DT</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Dissecting the genomic complexity underlying medulloblastoma</article-title><source>Nature</source><volume>488</volume><fpage>100</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1038/nature11284</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanai</surname><given-names>Y</given-names></name><name><surname>Dohmae</surname><given-names>N</given-names></name><name><surname>Hirokawa</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Kinesin transports RNA: isolation and characterization of an RNA-transporting granule</article-title><source>Neuron</source><volume>43</volume><fpage>513</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2004.07.022</pub-id><pub-id pub-id-type="pmid">15312650</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keene</surname><given-names>JD</given-names></name><name><surname>Komisarow</surname><given-names>JM</given-names></name><name><surname>Friedersdorf</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts</article-title><source>Nature Protocols</source><volume>1</volume><fpage>302</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1038/nprot.2006.47</pub-id><pub-id pub-id-type="pmid">17406249</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kellaris</surname><given-names>G</given-names></name><name><surname>Khan</surname><given-names>K</given-names></name><name><surname>Baig</surname><given-names>SM</given-names></name><name><surname>Tsai</surname><given-names>IC</given-names></name><name><surname>Zamora</surname><given-names>FM</given-names></name><name><surname>Ruggieri</surname><given-names>P</given-names></name><name><surname>Natowicz</surname><given-names>MR</given-names></name><name><surname>Katsanis</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A hypomorphic inherited pathogenic variant in DDX3X causes male intellectual disability with additional neurodevelopmental and neurodegenerative features</article-title><source>Human Genomics</source><volume>12</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.1186/s40246-018-0141-y</pub-id><pub-id pub-id-type="pmid">29490693</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotov</surname><given-names>AA</given-names></name><name><surname>Olenkina</surname><given-names>OM</given-names></name><name><surname>Kibanov</surname><given-names>MV</given-names></name><name><surname>Olenina</surname><given-names>LV</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>RNA helicase Belle (DDX3) is essential for male germline stem cell maintenance and division in <italic>Drosophila</italic></article-title><source>Biochimica et Biophysica Acta</source><volume>1863</volume><fpage>1093</fpage><lpage>1105</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2016.02.006</pub-id><pub-id pub-id-type="pmid">26876306</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraushar</surname><given-names>ML</given-names></name><name><surname>Thompson</surname><given-names>K</given-names></name><name><surname>Wijeratne</surname><given-names>HRS</given-names></name><name><surname>Viljetic</surname><given-names>B</given-names></name><name><surname>Sakers</surname><given-names>K</given-names></name><name><surname>Marson</surname><given-names>JW</given-names></name><name><surname>Kontoyiannis</surname><given-names>DL</given-names></name><name><surname>Buyske</surname><given-names>S</given-names></name><name><surname>Hart</surname><given-names>RP</given-names></name><name><surname>Rasin</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Temporally defined neocortical translation and polysome assembly are determined by the RNA-binding protein Hu antigen R</article-title><source>PNAS</source><volume>111</volume><fpage>E3815</fpage><lpage>E3824</lpage><pub-id pub-id-type="doi">10.1073/pnas.1408305111</pub-id><pub-id pub-id-type="pmid">25157170</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kriegstein</surname><given-names>A</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The glial nature of embryonic and adult neural stem cells</article-title><source>Annual Review of Neuroscience</source><volume>32</volume><fpage>149</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.051508.135600</pub-id><pub-id pub-id-type="pmid">19555289</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>C</given-names></name><name><surname>Huttner</surname><given-names>WB</given-names></name><name><surname>Calegari</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cdk4/cyclinD1 overexpression in neural stem cells shortens G1, delays neurogenesis, and promotes the generation and expansion of basal progenitors</article-title><source>Cell Stem Cell</source><volume>5</volume><fpage>320</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2009.05.026</pub-id><pub-id pub-id-type="pmid">19733543</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fast gapped-read alignment with Bowtie 2</article-title><source>Nature Methods</source><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmid">22388286</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Katyal</surname><given-names>S</given-names></name><name><surname>Downing</surname><given-names>SM</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Russell</surname><given-names>HR</given-names></name><name><surname>McKinnon</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Neurogenesis requires TopBP1 to prevent catastrophic replicative DNA damage in early progenitors</article-title><source>Nature Neuroscience</source><volume>15</volume><fpage>819</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1038/nn.3097</pub-id><pub-id pub-id-type="pmid">22522401</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lennox</surname><given-names>AL</given-names></name><name><surname>Hoye</surname><given-names>ML</given-names></name><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Johnson-Kerner</surname><given-names>BL</given-names></name><name><surname>Suit</surname><given-names>LA</given-names></name><name><surname>Venkataramanan</surname><given-names>S</given-names></name><name><surname>Sheehan</surname><given-names>CJ</given-names></name><name><surname>Alsina</surname><given-names>FC</given-names></name><name><surname>Fregeau</surname><given-names>B</given-names></name><name><surname>Aldinger</surname><given-names>KA</given-names></name><name><surname>Moey</surname><given-names>C</given-names></name><name><surname>Lobach</surname><given-names>I</given-names></name><name><surname>Afenjar</surname><given-names>A</given-names></name><name><surname>Babovic-Vuksanovic</surname><given-names>D</given-names></name><name><surname>Bézieau</surname><given-names>S</given-names></name><name><surname>Blackburn</surname><given-names>PR</given-names></name><name><surname>Bunt</surname><given-names>J</given-names></name><name><surname>Burglen</surname><given-names>L</given-names></name><name><surname>Campeau</surname><given-names>PM</given-names></name><name><surname>Charles</surname><given-names>P</given-names></name><name><surname>Chung</surname><given-names>BHY</given-names></name><name><surname>Cogné</surname><given-names>B</given-names></name><name><surname>Curry</surname><given-names>C</given-names></name><name><surname>D’Agostino</surname><given-names>MD</given-names></name><name><surname>Di Donato</surname><given-names>N</given-names></name><name><surname>Faivre</surname><given-names>L</given-names></name><name><surname>Héron</surname><given-names>D</given-names></name><name><surname>Innes</surname><given-names>AM</given-names></name><name><surname>Isidor</surname><given-names>B</given-names></name><name><surname>Keren</surname><given-names>B</given-names></name><name><surname>Kimball</surname><given-names>A</given-names></name><name><surname>Klee</surname><given-names>EW</given-names></name><name><surname>Kuentz</surname><given-names>P</given-names></name><name><surname>Küry</surname><given-names>S</given-names></name><name><surname>Martin-Coignard</surname><given-names>D</given-names></name><name><surname>Mirzaa</surname><given-names>G</given-names></name><name><surname>Mignot</surname><given-names>C</given-names></name><name><surname>Miyake</surname><given-names>N</given-names></name><name><surname>Matsumoto</surname><given-names>N</given-names></name><name><surname>Fujita</surname><given-names>A</given-names></name><name><surname>Nava</surname><given-names>C</given-names></name><name><surname>Nizon</surname><given-names>M</given-names></name><name><surname>Rodriguez</surname><given-names>D</given-names></name><name><surname>Blok</surname><given-names>LS</given-names></name><name><surname>Thauvin-Robinet</surname><given-names>C</given-names></name><name><surname>Thevenon</surname><given-names>J</given-names></name><name><surname>Vincent</surname><given-names>M</given-names></name><name><surname>Ziegler</surname><given-names>A</given-names></name><name><surname>Dobyns</surname><given-names>W</given-names></name><name><surname>Richards</surname><given-names>LJ</given-names></name><name><surname>Barkovich</surname><given-names>AJ</given-names></name><name><surname>Floor</surname><given-names>SN</given-names></name><name><surname>Silver</surname><given-names>DL</given-names></name><name><surname>Sherr</surname><given-names>EH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pathogenic DDX3X Mutations Impair RNA Metabolism and Neurogenesis during Fetal Cortical Development</article-title><source>Neuron</source><volume>106</volume><fpage>404</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2020.01.042</pub-id><pub-id pub-id-type="pmid">32135084</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wan</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Huo</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Sha</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>DDX3X regulates cell survival and cell cycle during mouse early embryonic development</article-title><source>Journal of Biomedical Research</source><volume>28</volume><fpage>282</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.7555/JBR.27.20130047</pub-id><pub-id pub-id-type="pmid">25050112</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Tyler</surname><given-names>WA</given-names></name><name><surname>Zeldich</surname><given-names>E</given-names></name><name><surname>Santpere Baró</surname><given-names>G</given-names></name><name><surname>Okamoto</surname><given-names>M</given-names></name><name><surname>Gao</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Sestan</surname><given-names>N</given-names></name><name><surname>Haydar</surname><given-names>TF</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Transcriptional priming as a conserved mechanism of lineage diversification in the developing mouse and human neocortex</article-title><source>Science Advances</source><volume>6</volume><elocation-id>45</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abd2068</pub-id><pub-id pub-id-type="pmid">33158872</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lodato</surname><given-names>S</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Generating neuronal diversity in the mammalian cerebral cortex</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>31</volume><fpage>699</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100814-125353</pub-id><pub-id pub-id-type="pmid">26359774</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madisen</surname><given-names>L</given-names></name><name><surname>Zwingman</surname><given-names>TA</given-names></name><name><surname>Sunkin</surname><given-names>SM</given-names></name><name><surname>Oh</surname><given-names>SW</given-names></name><name><surname>Zariwala</surname><given-names>HA</given-names></name><name><surname>Gu</surname><given-names>H</given-names></name><name><surname>Ng</surname><given-names>LL</given-names></name><name><surname>Palmiter</surname><given-names>RD</given-names></name><name><surname>Hawrylycz</surname><given-names>MJ</given-names></name><name><surname>Jones</surname><given-names>AR</given-names></name><name><surname>Lein</surname><given-names>ES</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A robust and high-throughput Cre reporting and characterization system for the whole mouse brain</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1038/nn.2467</pub-id><pub-id pub-id-type="pmid">20023653</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>H</given-names></name><name><surname>Pilaz</surname><given-names>LJ</given-names></name><name><surname>McMahon</surname><given-names>JJ</given-names></name><name><surname>Golzio</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Katsanis</surname><given-names>N</given-names></name><name><surname>Silver</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Rbm8a haploinsufficiency disrupts embryonic cortical development resulting in microcephaly</article-title><source>The Journal of Neuroscience</source><volume>35</volume><fpage>7003</fpage><lpage>7018</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0018-15.2015</pub-id><pub-id pub-id-type="pmid">25948253</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell-Dick</surname><given-names>A</given-names></name><name><surname>Chalem</surname><given-names>A</given-names></name><name><surname>Pilaz</surname><given-names>LJ</given-names></name><name><surname>Silver</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Acute Lengthening of Progenitor Mitosis Influences Progeny Fate during Cortical Development in vivo</article-title><source>Developmental Neuroscience</source><volume>41</volume><fpage>300</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1159/000507113</pub-id><pub-id pub-id-type="pmid">32541147</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monaghan</surname><given-names>CE</given-names></name><name><surname>Nechiporuk</surname><given-names>T</given-names></name><name><surname>Jeng</surname><given-names>S</given-names></name><name><surname>McWeeney</surname><given-names>SK</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Rosenfeld</surname><given-names>MG</given-names></name><name><surname>Mandel</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>REST corepressors RCOR1 and RCOR2 and the repressor INSM1 regulate the proliferation-differentiation balance in the developing brain</article-title><source>PNAS</source><volume>114</volume><fpage>E406</fpage><lpage>E415</lpage><pub-id pub-id-type="doi">10.1073/pnas.1620230114</pub-id><pub-id pub-id-type="pmid">28049845</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicola</surname><given-names>P</given-names></name><name><surname>Blackburn</surname><given-names>PR</given-names></name><name><surname>Rasmussen</surname><given-names>KJ</given-names></name><name><surname>Bertsch</surname><given-names>NL</given-names></name><name><surname>Klee</surname><given-names>EW</given-names></name><name><surname>Hasadsri</surname><given-names>L</given-names></name><name><surname>Pichurin</surname><given-names>PN</given-names></name><name><surname>Rankin</surname><given-names>J</given-names></name><name><surname>Raymond</surname><given-names>FL</given-names></name><name><surname>Study</surname><given-names>DDD</given-names></name><name><surname>Clayton-Smith</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>De novo <italic>DDX3X</italic> missense variants in males appear viable and contribute to syndromic intellectual disability</article-title><source>American Journal of Medical Genetics Part A</source><volume>179</volume><fpage>570</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.61061</pub-id><pub-id pub-id-type="pmid">30734472</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>S</given-names></name><name><surname>Flynn</surname><given-names>RA</given-names></name><name><surname>Floor</surname><given-names>SN</given-names></name><name><surname>Purzner</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>L</given-names></name><name><surname>Do</surname><given-names>BT</given-names></name><name><surname>Schubert</surname><given-names>S</given-names></name><name><surname>Vaka</surname><given-names>D</given-names></name><name><surname>Morrissy</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Kool</surname><given-names>M</given-names></name><name><surname>Hovestadt</surname><given-names>V</given-names></name><name><surname>Jones</surname><given-names>DTW</given-names></name><name><surname>Northcott</surname><given-names>PA</given-names></name><name><surname>Risch</surname><given-names>T</given-names></name><name><surname>Warnatz</surname><given-names>H-J</given-names></name><name><surname>Yaspo</surname><given-names>M-L</given-names></name><name><surname>Adams</surname><given-names>CM</given-names></name><name><surname>Leib</surname><given-names>RD</given-names></name><name><surname>Breese</surname><given-names>M</given-names></name><name><surname>Marra</surname><given-names>MA</given-names></name><name><surname>Malkin</surname><given-names>D</given-names></name><name><surname>Lichter</surname><given-names>P</given-names></name><name><surname>Doudna</surname><given-names>JA</given-names></name><name><surname>Pfister</surname><given-names>SM</given-names></name><name><surname>Taylor</surname><given-names>MD</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name><name><surname>Cho</surname><given-names>Y-J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress</article-title><source>Oncotarget</source><volume>7</volume><fpage>28169</fpage><lpage>28182</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.8612</pub-id><pub-id pub-id-type="pmid">27058758</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patmore</surname><given-names>DM</given-names></name><name><surname>Jassim</surname><given-names>A</given-names></name><name><surname>Nathan</surname><given-names>E</given-names></name><name><surname>Gilbertson</surname><given-names>RJ</given-names></name><name><surname>Tahan</surname><given-names>D</given-names></name><name><surname>Hoffmann</surname><given-names>N</given-names></name><name><surname>Tong</surname><given-names>Y</given-names></name><name><surname>Smith</surname><given-names>KS</given-names></name><name><surname>Kanneganti</surname><given-names>TD</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Taylor</surname><given-names>MD</given-names></name><name><surname>Northcott</surname><given-names>P</given-names></name><name><surname>Gilbertson</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>DDX3X Suppresses the Susceptibility of Hindbrain Lineages to Medulloblastoma</article-title><source>Developmental Cell</source><volume>54</volume><fpage>455</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2020.05.027</pub-id><pub-id pub-id-type="pmid">32553121</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilaz</surname><given-names>LJ</given-names></name><name><surname>Patti</surname><given-names>D</given-names></name><name><surname>Marcy</surname><given-names>G</given-names></name><name><surname>Ollier</surname><given-names>E</given-names></name><name><surname>Pfister</surname><given-names>S</given-names></name><name><surname>Douglas</surname><given-names>RJ</given-names></name><name><surname>Betizeau</surname><given-names>M</given-names></name><name><surname>Gautier</surname><given-names>E</given-names></name><name><surname>Cortay</surname><given-names>V</given-names></name><name><surname>Doerflinger</surname><given-names>N</given-names></name><name><surname>Kennedy</surname><given-names>H</given-names></name><name><surname>Dehay</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Forced G1-phase reduction alters mode of division, neuron number, and laminar phenotype in the cerebral cortex</article-title><source>PNAS</source><volume>106</volume><fpage>21924</fpage><lpage>21929</lpage><pub-id pub-id-type="doi">10.1073/pnas.0909894106</pub-id><pub-id pub-id-type="pmid">19959663</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilaz</surname><given-names>LJ</given-names></name><name><surname>McMahon</surname><given-names>JJ</given-names></name><name><surname>Miller</surname><given-names>EE</given-names></name><name><surname>Lennox</surname><given-names>AL</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Salmon</surname><given-names>E</given-names></name><name><surname>Silver</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Prolonged Mitosis of Neural Progenitors Alters Cell Fate in the Developing Brain</article-title><source>Neuron</source><volume>89</volume><fpage>83</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.12.007</pub-id><pub-id pub-id-type="pmid">26748089</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polioudakis</surname><given-names>D</given-names></name><name><surname>de la Torre-Ubieta</surname><given-names>L</given-names></name><name><surname>Langerman</surname><given-names>J</given-names></name><name><surname>Elkins</surname><given-names>AG</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Stein</surname><given-names>JL</given-names></name><name><surname>Vuong</surname><given-names>CK</given-names></name><name><surname>Nichterwitz</surname><given-names>S</given-names></name><name><surname>Gevorgian</surname><given-names>M</given-names></name><name><surname>Opland</surname><given-names>CK</given-names></name><name><surname>Lu</surname><given-names>D</given-names></name><name><surname>Connell</surname><given-names>W</given-names></name><name><surname>Ruzzo</surname><given-names>EK</given-names></name><name><surname>Lowe</surname><given-names>JK</given-names></name><name><surname>Hadzic</surname><given-names>T</given-names></name><name><surname>Hinz</surname><given-names>FI</given-names></name><name><surname>Sabri</surname><given-names>S</given-names></name><name><surname>Lowry</surname><given-names>WE</given-names></name><name><surname>Gerstein</surname><given-names>MB</given-names></name><name><surname>Plath</surname><given-names>K</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A Single-Cell Transcriptomic Atlas of Human Neocortical Development during Mid-gestation</article-title><source>Neuron</source><volume>103</volume><fpage>785</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.06.011</pub-id><pub-id pub-id-type="pmid">31303374</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pugh</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations</article-title><source>Nature</source><volume>488</volume><fpage>106</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1038/nature11329</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinn</surname><given-names>JC</given-names></name><name><surname>Molinek</surname><given-names>M</given-names></name><name><surname>Martynoga</surname><given-names>BS</given-names></name><name><surname>Zaki</surname><given-names>PA</given-names></name><name><surname>Faedo</surname><given-names>A</given-names></name><name><surname>Bulfone</surname><given-names>A</given-names></name><name><surname>Hevner</surname><given-names>RF</given-names></name><name><surname>West</surname><given-names>JD</given-names></name><name><surname>Price</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Pax6 controls cerebral cortical cell number by regulating exit from the cell cycle and specifies cortical cell identity by a cell autonomous mechanism</article-title><source>Developmental Biology</source><volume>302</volume><fpage>50</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.08.035</pub-id><pub-id pub-id-type="pmid">16979618</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>G</given-names></name><name><surname>Parker</surname><given-names>M</given-names></name><name><surname>Kranenburg</surname><given-names>TA</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Phoenix</surname><given-names>TN</given-names></name><name><surname>Hedlund</surname><given-names>E</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Chalhoub</surname><given-names>N</given-names></name><name><surname>Baker</surname><given-names>SJ</given-names></name><name><surname>Huether</surname><given-names>R</given-names></name><name><surname>Kriwacki</surname><given-names>R</given-names></name><name><surname>Curley</surname><given-names>N</given-names></name><name><surname>Thiruvenkatam</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Rusch</surname><given-names>M</given-names></name><name><surname>Hong</surname><given-names>X</given-names></name><name><surname>Becksfort</surname><given-names>J</given-names></name><name><surname>Gupta</surname><given-names>P</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Easton</surname><given-names>J</given-names></name><name><surname>Vadodaria</surname><given-names>B</given-names></name><name><surname>Onar-Thomas</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Pounds</surname><given-names>S</given-names></name><name><surname>Paugh</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Kawauchi</surname><given-names>D</given-names></name><name><surname>Roussel</surname><given-names>MF</given-names></name><name><surname>Finkelstein</surname><given-names>D</given-names></name><name><surname>Ellison</surname><given-names>DW</given-names></name><name><surname>Lau</surname><given-names>CC</given-names></name><name><surname>Bouffet</surname><given-names>E</given-names></name><name><surname>Hassall</surname><given-names>T</given-names></name><name><surname>Gururangan</surname><given-names>S</given-names></name><name><surname>Cohn</surname><given-names>R</given-names></name><name><surname>Fulton</surname><given-names>RS</given-names></name><name><surname>Fulton</surname><given-names>LL</given-names></name><name><surname>Dooling</surname><given-names>DJ</given-names></name><name><surname>Ochoa</surname><given-names>K</given-names></name><name><surname>Gajjar</surname><given-names>A</given-names></name><name><surname>Mardis</surname><given-names>ER</given-names></name><name><surname>Wilson</surname><given-names>RK</given-names></name><name><surname>Downing</surname><given-names>JR</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Gilbertson</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Novel mutations target distinct subgroups of medulloblastoma</article-title><source>Nature</source><volume>488</volume><fpage>43</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1038/nature11213</pub-id><pub-id pub-id-type="pmid">22722829</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruzzo</surname><given-names>EK</given-names></name><name><surname>Pérez-Cano</surname><given-names>L</given-names></name><name><surname>Jung</surname><given-names>J-Y</given-names></name><name><surname>Wang</surname><given-names>L-K</given-names></name><name><surname>Kashef-Haghighi</surname><given-names>D</given-names></name><name><surname>Hartl</surname><given-names>C</given-names></name><name><surname>Singh</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Hoekstra</surname><given-names>JN</given-names></name><name><surname>Leventhal</surname><given-names>O</given-names></name><name><surname>Leppä</surname><given-names>VM</given-names></name><name><surname>Gandal</surname><given-names>MJ</given-names></name><name><surname>Paskov</surname><given-names>K</given-names></name><name><surname>Stockham</surname><given-names>N</given-names></name><name><surname>Polioudakis</surname><given-names>D</given-names></name><name><surname>Lowe</surname><given-names>JK</given-names></name><name><surname>Prober</surname><given-names>DA</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name><name><surname>Wall</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks</article-title><source>Cell</source><volume>178</volume><fpage>850</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.07.015</pub-id><pub-id pub-id-type="pmid">31398340</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scala</surname><given-names>M</given-names></name><name><surname>Torella</surname><given-names>A</given-names></name><name><surname>Severino</surname><given-names>M</given-names></name><name><surname>Morana</surname><given-names>G</given-names></name><name><surname>Castello</surname><given-names>R</given-names></name><name><surname>Accogli</surname><given-names>A</given-names></name><name><surname>Verrico</surname><given-names>A</given-names></name><name><surname>Vari</surname><given-names>MS</given-names></name><name><surname>Cappuccio</surname><given-names>G</given-names></name><name><surname>Pinelli</surname><given-names>M</given-names></name><name><surname>Vitiello</surname><given-names>G</given-names></name><name><surname>Terrone</surname><given-names>G</given-names></name><name><surname>D’Amico</surname><given-names>A</given-names></name><name><surname>consortium</surname><given-names>T</given-names></name><name><surname>Nigro</surname><given-names>V</given-names></name><name><surname>Capra</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Three de novo DDX3X variants associated with distinctive brain developmental abnormalities and brain tumor in intellectually disabled females</article-title><source>European Journal of Human Genetics</source><volume>27</volume><fpage>1254</fpage><lpage>1259</lpage><pub-id pub-id-type="doi">10.1038/s41431-019-0392-7</pub-id><pub-id pub-id-type="pmid">30936465</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Silver</surname><given-names>DL</given-names></name><name><surname>Rakic</surname><given-names>P</given-names></name><name><surname>Grove</surname><given-names>EA</given-names></name><name><surname>Haydar</surname><given-names>TF</given-names></name><name><surname>Hensch</surname><given-names>TK</given-names></name><name><surname>Huttner</surname><given-names>WB</given-names></name><name><surname>Molnar</surname><given-names>Z</given-names></name><name><surname>Rubenstein</surname><given-names>JL</given-names></name><name><surname>Sestan</surname><given-names>N</given-names></name><name><surname>Stryker</surname><given-names>MP</given-names></name><name><surname>Sur</surname><given-names>M</given-names></name><name><surname>Tosches</surname><given-names>MA</given-names></name><name><surname>Walsh</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2019">2019</year><chapter-title>Evolution and Ontogenetic Development of Cortical Structures</chapter-title><person-group person-group-type="editor"><name><surname>Rakic</surname><given-names>P</given-names></name></person-group><source>The Neocortex</source><publisher-name>MIT Press</publisher-name><fpage>61</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.7551/mitpress/12593.001.0001</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snijders Blok</surname><given-names>L</given-names></name><name><surname>Madsen</surname><given-names>E</given-names></name><name><surname>Juusola</surname><given-names>J</given-names></name><name><surname>Gilissen</surname><given-names>C</given-names></name><name><surname>Baralle</surname><given-names>D</given-names></name><name><surname>Reijnders</surname><given-names>MRF</given-names></name><name><surname>Venselaar</surname><given-names>H</given-names></name><name><surname>Helsmoortel</surname><given-names>C</given-names></name><name><surname>Cho</surname><given-names>MT</given-names></name><name><surname>Hoischen</surname><given-names>A</given-names></name><name><surname>Vissers</surname><given-names>LELM</given-names></name><name><surname>Koemans</surname><given-names>TS</given-names></name><name><surname>Wissink-Lindhout</surname><given-names>W</given-names></name><name><surname>Eichler</surname><given-names>EE</given-names></name><name><surname>Romano</surname><given-names>C</given-names></name><name><surname>Van Esch</surname><given-names>H</given-names></name><name><surname>Stumpel</surname><given-names>C</given-names></name><name><surname>Vreeburg</surname><given-names>M</given-names></name><name><surname>Smeets</surname><given-names>E</given-names></name><name><surname>Oberndorff</surname><given-names>K</given-names></name><name><surname>van Bon</surname><given-names>BWM</given-names></name><name><surname>Shaw</surname><given-names>M</given-names></name><name><surname>Gecz</surname><given-names>J</given-names></name><name><surname>Haan</surname><given-names>E</given-names></name><name><surname>Bienek</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>C</given-names></name><name><surname>Loeys</surname><given-names>BL</given-names></name><name><surname>Van Dijck</surname><given-names>A</given-names></name><name><surname>Innes</surname><given-names>AM</given-names></name><name><surname>Racher</surname><given-names>H</given-names></name><name><surname>Vermeer</surname><given-names>S</given-names></name><name><surname>Di Donato</surname><given-names>N</given-names></name><name><surname>Rump</surname><given-names>A</given-names></name><name><surname>Tatton-Brown</surname><given-names>K</given-names></name><name><surname>Parker</surname><given-names>MJ</given-names></name><name><surname>Henderson</surname><given-names>A</given-names></name><name><surname>Lynch</surname><given-names>SA</given-names></name><name><surname>Fryer</surname><given-names>A</given-names></name><name><surname>Ross</surname><given-names>A</given-names></name><name><surname>Vasudevan</surname><given-names>P</given-names></name><name><surname>Kini</surname><given-names>U</given-names></name><name><surname>Newbury-Ecob</surname><given-names>R</given-names></name><name><surname>Chandler</surname><given-names>K</given-names></name><name><surname>Male</surname><given-names>A</given-names></name><collab>DDD Study</collab><name><surname>Dijkstra</surname><given-names>S</given-names></name><name><surname>Schieving</surname><given-names>J</given-names></name><name><surname>Giltay</surname><given-names>J</given-names></name><name><surname>van Gassen</surname><given-names>KLI</given-names></name><name><surname>Schuurs-Hoeijmakers</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>PL</given-names></name><name><surname>Pediaditakis</surname><given-names>I</given-names></name><name><surname>Haas</surname><given-names>SA</given-names></name><name><surname>Retterer</surname><given-names>K</given-names></name><name><surname>Reed</surname><given-names>P</given-names></name><name><surname>Monaghan</surname><given-names>KG</given-names></name><name><surname>Haverfield</surname><given-names>E</given-names></name><name><surname>Natowicz</surname><given-names>M</given-names></name><name><surname>Myers</surname><given-names>A</given-names></name><name><surname>Kruer</surname><given-names>MC</given-names></name><name><surname>Stein</surname><given-names>Q</given-names></name><name><surname>Strauss</surname><given-names>KA</given-names></name><name><surname>Brigatti</surname><given-names>KW</given-names></name><name><surname>Keating</surname><given-names>K</given-names></name><name><surname>Burton</surname><given-names>BK</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Charrow</surname><given-names>J</given-names></name><name><surname>Norman</surname><given-names>J</given-names></name><name><surname>Foster-Barber</surname><given-names>A</given-names></name><name><surname>Kline</surname><given-names>AD</given-names></name><name><surname>Kimball</surname><given-names>A</given-names></name><name><surname>Zackai</surname><given-names>E</given-names></name><name><surname>Harr</surname><given-names>M</given-names></name><name><surname>Fox</surname><given-names>J</given-names></name><name><surname>McLaughlin</surname><given-names>J</given-names></name><name><surname>Lindstrom</surname><given-names>K</given-names></name><name><surname>Haude</surname><given-names>KM</given-names></name><name><surname>van Roozendaal</surname><given-names>K</given-names></name><name><surname>Brunner</surname><given-names>H</given-names></name><name><surname>Chung</surname><given-names>WK</given-names></name><name><surname>Kooy</surname><given-names>RF</given-names></name><name><surname>Pfundt</surname><given-names>R</given-names></name><name><surname>Kalscheuer</surname><given-names>V</given-names></name><name><surname>Mehta</surname><given-names>SG</given-names></name><name><surname>Katsanis</surname><given-names>N</given-names></name><name><surname>Kleefstra</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling</article-title><source>American Journal of Human Genetics</source><volume>97</volume><fpage>343</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2015.07.004</pub-id><pub-id pub-id-type="pmid">26235985</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szappanos</surname><given-names>D</given-names></name><name><surname>Tschismarov</surname><given-names>R</given-names></name><name><surname>Perlot</surname><given-names>T</given-names></name><name><surname>Westermayer</surname><given-names>S</given-names></name><name><surname>Fischer</surname><given-names>K</given-names></name><name><surname>Platanitis</surname><given-names>E</given-names></name><name><surname>Kallinger</surname><given-names>F</given-names></name><name><surname>Novatchkova</surname><given-names>M</given-names></name><name><surname>Lassnig</surname><given-names>C</given-names></name><name><surname>Müller</surname><given-names>M</given-names></name><name><surname>Sexl</surname><given-names>V</given-names></name><name><surname>Bennett</surname><given-names>KL</given-names></name><name><surname>Foong-Sobis</surname><given-names>M</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name><name><surname>Decker</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The RNA helicase DDX3X is an essential mediator of innate antimicrobial immunity</article-title><source>PLOS Pathogens</source><volume>14</volume><elocation-id>e1007397</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007397</pub-id><pub-id pub-id-type="pmid">30475900</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Nowakowski</surname><given-names>RS</given-names></name><name><surname>Caviness</surname><given-names>VS</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>The cell cycle of the pseudostratified ventricular epithelium of the embryonic murine cerebral wall</article-title><source>The Journal of Neuroscience</source><volume>15</volume><fpage>6046</fpage><lpage>6057</lpage><pub-id pub-id-type="pmid">7666188</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takata</surname><given-names>A</given-names></name><name><surname>Miyake</surname><given-names>N</given-names></name><name><surname>Tsurusaki</surname><given-names>Y</given-names></name><name><surname>Fukai</surname><given-names>R</given-names></name><name><surname>Miyatake</surname><given-names>S</given-names></name><name><surname>Koshimizu</surname><given-names>E</given-names></name><name><surname>Kushima</surname><given-names>I</given-names></name><name><surname>Okada</surname><given-names>T</given-names></name><name><surname>Morikawa</surname><given-names>M</given-names></name><name><surname>Uno</surname><given-names>Y</given-names></name><name><surname>Ishizuka</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Tsujii</surname><given-names>M</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Toyota</surname><given-names>T</given-names></name><name><surname>Okamoto</surname><given-names>N</given-names></name><name><surname>Hiraki</surname><given-names>Y</given-names></name><name><surname>Hashimoto</surname><given-names>R</given-names></name><name><surname>Yasuda</surname><given-names>Y</given-names></name><name><surname>Saitoh</surname><given-names>S</given-names></name><name><surname>Ohashi</surname><given-names>K</given-names></name><name><surname>Sakai</surname><given-names>Y</given-names></name><name><surname>Ohga</surname><given-names>S</given-names></name><name><surname>Hara</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>A</given-names></name><name><surname>Seiwa</surname><given-names>C</given-names></name><name><surname>Shirahata</surname><given-names>E</given-names></name><name><surname>Osaka</surname><given-names>H</given-names></name><name><surname>Matsumoto</surname><given-names>A</given-names></name><name><surname>Takeshita</surname><given-names>S</given-names></name><name><surname>Tohyama</surname><given-names>J</given-names></name><name><surname>Saikusa</surname><given-names>T</given-names></name><name><surname>Matsuishi</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Tsuboi</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Saitsu</surname><given-names>H</given-names></name><name><surname>Nakashima</surname><given-names>M</given-names></name><name><surname>Mizuguchi</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>F</given-names></name><name><surname>Mori</surname><given-names>N</given-names></name><name><surname>Ozaki</surname><given-names>N</given-names></name><name><surname>Matsumoto</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integrative Analyses of De Novo Mutations Provide Deeper Biological Insights into Autism Spectrum Disorder</article-title><source>Cell Reports</source><volume>22</volume><fpage>734</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.12.074</pub-id><pub-id pub-id-type="pmid">29346770</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Levy</surname><given-names>T</given-names></name><name><surname>Guillory</surname><given-names>S</given-names></name><name><surname>Halpern</surname><given-names>D</given-names></name><name><surname>Zweifach</surname><given-names>J</given-names></name><name><surname>Giserman-Kiss</surname><given-names>I</given-names></name><name><surname>Foss-Feig</surname><given-names>JH</given-names></name><name><surname>Frank</surname><given-names>Y</given-names></name><name><surname>Lozano</surname><given-names>R</given-names></name><name><surname>Belani</surname><given-names>P</given-names></name><name><surname>Layton</surname><given-names>C</given-names></name><name><surname>Lerman</surname><given-names>B</given-names></name><name><surname>Frowner</surname><given-names>E</given-names></name><name><surname>Breen</surname><given-names>MS</given-names></name><name><surname>De Rubeis</surname><given-names>S</given-names></name><name><surname>Kostic</surname><given-names>A</given-names></name><name><surname>Kolevzon</surname><given-names>A</given-names></name><name><surname>Buxbaum</surname><given-names>JD</given-names></name><name><surname>Siper</surname><given-names>PM</given-names></name><name><surname>Grice</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Prospective and detailed behavioral phenotyping in DDX3X syndrome</article-title><source>Molecular Autism</source><volume>12</volume><elocation-id>36</elocation-id><pub-id pub-id-type="doi">10.1186/s13229-021-00431-z</pub-id><pub-id pub-id-type="pmid">33993884</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telley</surname><given-names>L</given-names></name><name><surname>Agirman</surname><given-names>G</given-names></name><name><surname>Prados</surname><given-names>J</given-names></name><name><surname>Amberg</surname><given-names>N</given-names></name><name><surname>Fièvre</surname><given-names>S</given-names></name><name><surname>Oberst</surname><given-names>P</given-names></name><name><surname>Bartolini</surname><given-names>G</given-names></name><name><surname>Vitali</surname><given-names>I</given-names></name><name><surname>Cadilhac</surname><given-names>C</given-names></name><name><surname>Hippenmeyer</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>L</given-names></name><name><surname>Dayer</surname><given-names>A</given-names></name><name><surname>Jabaudon</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex</article-title><source>Science (New York, N.Y.)</source><volume>364</volume><elocation-id>6440</elocation-id><pub-id pub-id-type="doi">10.1126/science.aav2522</pub-id><pub-id pub-id-type="pmid">31073041</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsanov</surname><given-names>N</given-names></name><name><surname>Samacoits</surname><given-names>A</given-names></name><name><surname>Chouaib</surname><given-names>R</given-names></name><name><surname>Traboulsi</surname><given-names>AM</given-names></name><name><surname>Gostan</surname><given-names>T</given-names></name><name><surname>Weber</surname><given-names>C</given-names></name><name><surname>Zimmer</surname><given-names>C</given-names></name><name><surname>Zibara</surname><given-names>K</given-names></name><name><surname>Walter</surname><given-names>T</given-names></name><name><surname>Peter</surname><given-names>M</given-names></name><name><surname>Bertrand</surname><given-names>E</given-names></name><name><surname>Mueller</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>smiFISH and FISH-quant - a flexible single RNA detection approach with super-resolution capability</article-title><source>Nucleic Acids Research</source><volume>44</volume><elocation-id>e165</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkw784</pub-id><pub-id pub-id-type="pmid">27599845</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tukiainen</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Landscape of X chromosome inactivation across human tissues</article-title><source>Nature</source><volume>550</volume><fpage>244</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1038/nature24265</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkataramanan</surname><given-names>S</given-names></name><name><surname>Gadek</surname><given-names>M</given-names></name><name><surname>Calviello</surname><given-names>L</given-names></name><name><surname>Wilkins</surname><given-names>K</given-names></name><name><surname>Floor</surname><given-names>SN</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>DDX3X and DDX3Y are redundant in protein synthesis</article-title><source>RNA (New York, N.Y.)</source><volume>27</volume><fpage>1577</fpage><lpage>1588</lpage><pub-id pub-id-type="doi">10.1261/rna.078926.121</pub-id><pub-id pub-id-type="pmid">34535544</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Bai</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>LSD1 co-repressor Rcor2 orchestrates neurogenesis in the developing mouse brain</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>10481</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms10481</pub-id><pub-id pub-id-type="pmid">26795843</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Posey</surname><given-names>JE</given-names></name><name><surname>Rosenfeld</surname><given-names>JA</given-names></name><name><surname>Bacino</surname><given-names>CA</given-names></name><name><surname>Scaglia</surname><given-names>F</given-names></name><name><surname>Immken</surname><given-names>L</given-names></name><name><surname>Harris</surname><given-names>JM</given-names></name><name><surname>Hickey</surname><given-names>SE</given-names></name><name><surname>Mosher</surname><given-names>TM</given-names></name><name><surname>Slavotinek</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Beuten</surname><given-names>J</given-names></name><name><surname>Leduc</surname><given-names>MS</given-names></name><name><surname>He</surname><given-names>W</given-names></name><name><surname>Vetrini</surname><given-names>F</given-names></name><name><surname>Walkiewicz</surname><given-names>MA</given-names></name><name><surname>Bi</surname><given-names>W</given-names></name><name><surname>Xiao</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Shao</surname><given-names>Y</given-names></name><name><surname>Gezdirici</surname><given-names>A</given-names></name><name><surname>Gulec</surname><given-names>EY</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Darilek</surname><given-names>SA</given-names></name><name><surname>Hansen</surname><given-names>AW</given-names></name><name><surname>Khayat</surname><given-names>MM</given-names></name><name><surname>Pehlivan</surname><given-names>D</given-names></name><name><surname>Piard</surname><given-names>J</given-names></name><name><surname>Muzny</surname><given-names>DM</given-names></name><name><surname>Hanchard</surname><given-names>N</given-names></name><name><surname>Belmont</surname><given-names>JW</given-names></name><name><surname>Van Maldergem</surname><given-names>L</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Eldomery</surname><given-names>MK</given-names></name><name><surname>Akdemir</surname><given-names>ZC</given-names></name><name><surname>Adesina</surname><given-names>AM</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>Y-C</given-names></name><collab>Undiagnosed Diseases Network</collab><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Lupski</surname><given-names>JR</given-names></name><name><surname>Eng</surname><given-names>CM</given-names></name><name><surname>Xia</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Graham</surname><given-names>BH</given-names></name><name><surname>Moretti</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Phenotypic expansion in <italic>DDX3X</italic> - a common cause of intellectual disability in females</article-title><source>Annals of Clinical and Translational Neurology</source><volume>5</volume><fpage>1277</fpage><lpage>1285</lpage><pub-id pub-id-type="doi">10.1002/acn3.622</pub-id><pub-id pub-id-type="pmid">30349862</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willsey</surname><given-names>AJ</given-names></name><name><surname>Sanders</surname><given-names>SJ</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Dong</surname><given-names>S</given-names></name><name><surname>Tebbenkamp</surname><given-names>AT</given-names></name><name><surname>Muhle</surname><given-names>RA</given-names></name><name><surname>Reilly</surname><given-names>SK</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Fertuzinhos</surname><given-names>S</given-names></name><name><surname>Miller</surname><given-names>JA</given-names></name><name><surname>Murtha</surname><given-names>MT</given-names></name><name><surname>Bichsel</surname><given-names>C</given-names></name><name><surname>Niu</surname><given-names>W</given-names></name><name><surname>Cotney</surname><given-names>J</given-names></name><name><surname>Ercan-Sencicek</surname><given-names>AG</given-names></name><name><surname>Gockley</surname><given-names>J</given-names></name><name><surname>Gupta</surname><given-names>AR</given-names></name><name><surname>Han</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Hoffman</surname><given-names>EJ</given-names></name><name><surname>Klei</surname><given-names>L</given-names></name><name><surname>Lei</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Mane</surname><given-names>SM</given-names></name><name><surname>Lein</surname><given-names>ES</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Noonan</surname><given-names>JP</given-names></name><name><surname>Roeder</surname><given-names>K</given-names></name><name><surname>Devlin</surname><given-names>B</given-names></name><name><surname>Sestan</surname><given-names>N</given-names></name><name><surname>State</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism</article-title><source>Cell</source><volume>155</volume><fpage>997</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.10.020</pub-id><pub-id pub-id-type="pmid">24267886</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willsey</surname><given-names>HR</given-names></name><name><surname>Exner</surname><given-names>CRT</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Everitt</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Dea</surname><given-names>J</given-names></name><name><surname>Schmunk</surname><given-names>G</given-names></name><name><surname>Zaltsman</surname><given-names>Y</given-names></name><name><surname>Teerikorpi</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>AS</given-names></name><name><surname>Shin</surname><given-names>D</given-names></name><name><surname>Seyler</surname><given-names>M</given-names></name><name><surname>Nowakowski</surname><given-names>TJ</given-names></name><name><surname>Harland</surname><given-names>RM</given-names></name><name><surname>Willsey</surname><given-names>AJ</given-names></name><name><surname>State</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Parallel in vivo analysis of large-effect autism genes implicates cortical neurogenesis and estrogen in risk and resilience</article-title><source>Neuron</source><volume>109</volume><fpage>788</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2021.01.002</pub-id><pub-id pub-id-type="pmid">33497602</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witecka</surname><given-names>A</given-names></name><name><surname>Kwiatkowski</surname><given-names>S</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Drozak</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The Structure, Activity, and Function of the SETD3 Protein Histidine Methyltransferase</article-title><source>Life (Chicago, Ill.: 1978)</source><volume>11</volume><elocation-id>1040</elocation-id><pub-id pub-id-type="doi">10.3390/life11101040</pub-id><pub-id pub-id-type="pmid">34685411</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Rattner</surname><given-names>A</given-names></name><name><surname>Mo</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Smallwood</surname><given-names>PM</given-names></name><name><surname>Erlanger</surname><given-names>B</given-names></name><name><surname>Wheelan</surname><given-names>SJ</given-names></name><name><surname>Nathans</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cellular Resolution Maps of X Chromosome Inactivation: Implications for Neural Development, Function, and Disease</article-title><source>Neuron</source><volume>81</volume><fpage>103</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.051</pub-id><pub-id pub-id-type="pmid">24411735</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Smibert</surname><given-names>CA</given-names></name><name><surname>Kaplan</surname><given-names>DR</given-names></name><name><surname>Miller</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>An eIF4E1/4E-T Complex Determines the Genesis of Neurons from Precursors by Translationally Repressing a Proneurogenic Transcription Program</article-title><source>Neuron</source><volume>84</volume><fpage>723</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.10.022</pub-id><pub-id pub-id-type="pmid">25456498</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuen</surname><given-names>RK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder</article-title><source>Nature Neuroscience</source><volume>20</volume><fpage>602</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1038/nn.4524</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zahr</surname><given-names>SK</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Kazan</surname><given-names>H</given-names></name><name><surname>Borrett</surname><given-names>MJ</given-names></name><name><surname>Yuzwa</surname><given-names>SA</given-names></name><name><surname>Voronova</surname><given-names>A</given-names></name><name><surname>Kaplan</surname><given-names>DR</given-names></name><name><surname>Miller</surname><given-names>FD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A Translational Repression Complex in Developing Mammalian Neural Stem Cells that Regulates Neuronal Specification</article-title><source>Neuron</source><volume>97</volume><fpage>520</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.12.045</pub-id><pub-id pub-id-type="pmid">29395907</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>DEAD-Box RNA Helicases in Cell Cycle Control and Clinical Therapy</article-title><source>Cells</source><volume>10</volume><elocation-id>1540</elocation-id><pub-id pub-id-type="doi">10.3390/cells10061540</pub-id><pub-id pub-id-type="pmid">34207140</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78203.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gleeson</surname><given-names>Joseph G</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0420db125</institution-id><institution>Howard Hughes Medical Institute, The Rockefeller University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2022.02.21.481343" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2022.02.21.481343"/></front-stub><body><p>The paper beautifully documents the cortical developmental defects associated with DDX3X loss, detailing both the morphological, transcriptional, cell cycle, and protein translational defects in visually striking detail.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78203.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Gleeson</surname><given-names>Joseph G</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0420db125</institution-id><institution>Howard Hughes Medical Institute, The Rockefeller University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.02.21.481343">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.02.21.481343v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Aberrant cortical development is driven by impaired cell cycle and translational control in a DDX3X syndrome model&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1. It is unclear why the expression levels in the male cKO are reduced to levels comparable to the cHET females at D11.5 (Figure 1D, E), and not comparable to cKO females as one might expect. Could it be that the probes/primers used here are indeed specific for DDX3X or might they also detect DDX3Y. Is there is another explanation?</p><p>2. For their ribosomal profiling experiments, the authors focused on cKO females and males, while in the rest of the paper they argue that cKO males are actually comparable to cHET females. And then for polysome fractionation, they go back to cHET females. Those inconsistencies are not well justified in the manuscript. Since samples from cKO males and cKO females were used for the Ribo-seq and RNA-seq experiments, the rationale for using samples from cKO males and cHet females for the polysome fractionation experiment is unclear. Differences in RNA abundance attributed to developmental timepoints in RIBO seq vs. polysome fractionation (E11.5 vs. E14.5) might be due to different DDX3X levels.</p><p>3. Figure 6D used adjusted p-value &lt;0.1 as the threshold, which is not a typical practice. We recommend filtering target genes with a more stringent standard.</p><p>4. The validity of the cKO mouse should be further confirmed with quantification of DDX3X protein levels, in addition to the mRNA analyses.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>1. The authors should define the expression pattern of the Nex-Cre mouse in the text.</p><p>2. The authors should define different cell stainings better (e.g. what type of cells do Tbr-<italic>Sox2</italic>- cells represent).</p><p>3. How do the authors explain that there seem to be significantly more <italic>Sox2</italic><sup>+</sup>/EdU+ cells in Figure 4D, but not <italic>Sox2</italic><sup>+</sup> Tbr2- EdU+ cells in Figure 4 – figure 3B?</p><p>4. In Figure 5D, what does the white bar represent? Only 1 division or no division at all? This should be clarified in the legend.</p><p>5. The reference RK, C.Y. et al., is not written correctly, the first author should be Yuen, R.K.C.</p><p>6. The authors comment on the spectrum of nonsense mutations that may be either LOF or hypomorphic. It is unclear to me what the authors mean by this, could they clarify this statement?</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>1) De novo DDX3X human mutations are associated with intellectual disability and over 80% of patients show abnormal corpus callosum. Do heterozygous Ddx3x cKO female mice and/or cKO males display comparable corpus callosum and learning/behavior phenotypes?</p><p>2) The authors suggested that Ddx3y loss of function phenocopies Ddx3x lof with the CRISPR IUE assay. This point could be further strengthened with another control – Ddx3y sgRNA IUE in female embryos, which probably had been collected in parallel with the samples shown in Figure 2D. In addition, given that ~15% of cells underwent apoptosis in homozygous cKO females, does Ddx3y sgRNA IUE in cKO males induce similar effects?</p><p>3) The authors described Figure 4G as E14.5 but the brain sections appear much thinner (than Figure 4A for example) and more proliferative than typical E14.5 tissues.</p><p>4) Figure 6D used adjusted p-value &lt;0.1 as the threshold, which is not a typical practice. We recommend filtering target genes with a more stringent standard.</p><p>5) For Ddx3x dependent gene translation, are these Ribo-Seq targets directly regulated by Ddx3x? Are they overall enriched in certain biological functions?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.78203.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. It is unclear why the expression levels in the male cKO are reduced to levels comparable to the cHET females at D11.5 (Figure 1D, E), and not comparable to cKO females as one might expect. Could it be that the probes/primers used here are indeed specific for DDX3X or might they also detect DDX3Y. Is there is another explanation?</p></disp-quote><p>We apologize for the lack of clarity regarding this point. We quantified that WT females had ~25% higher levels of <italic>Ddx3x</italic> mRNA expression than WT males (Figure 1G). Thus, we originally plotted males and females separately to illustrate the reduction of <italic>Ddx3x</italic> in conditional mice relative to their sex-matched controls (original Figures 1D, E). Because females have higher levels than males at baseline, the relative reduction in <italic>Ddx3x</italic> levels in cHet females and cKO males is similar, particularly at E11. In this revision, we now plot all of the sexes together which makes it easier to compare levels across all genotypes (new Figures 1E and 1F). Our probes are specific for <italic>Ddx3x</italic>, as evidenced in Figure 2C (in which we knockdown <italic>Ddx3y</italic> but observe no change in <italic>Ddx3x</italic>).</p><p>Importantly, males also express <italic>Ddx3y</italic>, which acts redundantly with <italic>Ddx3x</italic>. While there are no available DDX3Y specific antibodies, <italic>Ddx3y</italic> is upregulated at the RNA level in cKO males (Figure 2A). Thus we posit that the overall levels of DDX3 protein in males and females is relatively similar.</p><disp-quote content-type="editor-comment"><p>2. For their ribosomal profiling experiments, the authors focused on cKO females and males, while in the rest of the paper they argue that cKO males are actually comparable to cHET females. And then for polysome fractionation, they go back to cHET females. Those inconsistencies are not well justified in the manuscript. Since samples from cKO males and cKO females were used for the Ribo-seq and RNA-seq experiments, the rationale for using samples from cKO males and cHet females for the polysome fractionation experiment is unclear. Differences in RNA abundance attributed to developmental timepoints in RIBO seq vs. polysome fractionation (E11.5 vs. E14.5) might be due to different DDX3X levels.</p></disp-quote><p>We thank the reviewers for this suggestion. While we did use cKO females and males for the ribosome profiling experiment, this was done for several reasons.</p><p>1) Ribo-seq is more technically challenging than a standard RNAseq experiment, so we aimed to maximize the effect of <italic>Ddx3x</italic> knockout by using the cKO females. Because of the profound apoptosis that begins at E12.5 in cKO females, we opted to do these experiments at E11.5 to avoid potential complications due to cell death and composition changes.</p><p>2) The bulk of our paper focuses on the cortical development phenotypes of the cHet females and cKO males (to best model <italic>DDX3X</italic> syndrome), with significant phenotypes at E14.5. Thus, we initially performed the polysome fractionation of these genotypes at E14.5 to determine whether any of the DDX3X-dependent translation changes might be contributing to phenotypes at this stage. We did not include cKO females in this assay because at E14.5, most of the cells in the cortex are apoptotic.</p><p>In response to reviewer concerns, in this revised manuscript we include new polysome fractionation analyses at E11.5 using cKO females and cKO males-this provides validation of Ribo-seq of the same genotypes. These data show significant enrichment in monosome fractions for 2 targets (<italic>Rcor2</italic> and <italic>Topbp1</italic>) and trends for a 3<sup>rd</sup> (<italic>Setd3</italic>, p=0.10). This also validates the same transcripts which are altered in polysomes at E14.5 in cHet females and cKO males. We include these new data in Figures 6H, J and Figure 6—figure supplement 2A,B.</p><p>We agree that differences in RNA abundance could be due to different developmental timepoints and DDX3X levels. We have included this important possibility in the discussion and removed this point from the results.</p><disp-quote content-type="editor-comment"><p>3. Figure 6D used adjusted p-value &lt;0.1 as the threshold, which is not a typical practice. We recommend filtering target genes with a more stringent standard.</p></disp-quote><p>We originally used a threshold of adjusted p-value &lt;0.1 because the Ribo-seq data is much more inherently noisy than a typical RNAseq dataset. However, to fit with more stringent standard practice we have re-graphed these data including only targets which are &lt;0.05. These modified data are found in Figures 6D, E.</p><disp-quote content-type="editor-comment"><p>4. The validity of the cKO mouse should be further confirmed with quantification of DDX3X protein levels, in addition to the mRNA analyses.</p></disp-quote><p>We thank the reviewers for this suggestion. We have performed western blots using E14.5 brains from cHet females and cKO males (n=2-4 for each genotype and sex). cKO females were not used at E14.5 due to massive apoptosis. We quantified one western but repeated westerns several times. These data show: (a) WT females have higher levels than WT males (consistent with RNA levels); (b) cHet females have lower levels than WT females; c) cKO males have markedly reduced DDX3X, relative to all genotypes. These data corroborate qPCR analyses in Figure 1, and further validate the mouse model. In addition, the marked absence of DDX3X in males further confirms this antibody is specific to DDX3X and appears to not cross react with DDX3Y (which we note in the figure legend for these data). Please see Figure 1—figure supplement 1A. It is also valuable to note that the cKO mouse we are using has previously been validated by western analysis, in the initial study reporting this mouse [1]. Further, there are no available commercial antibodies specific for DDX3Y. As noted in response 1, we posit that the overall levels of DDX3 protein in males and females is relatively similar given the function of <italic>Ddx3y</italic>.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>1. The authors should define the expression pattern of the Nex-Cre mouse in the text.</p></disp-quote><p>We apologize for this oversight and have updated the text accordingly (p. 7).</p><disp-quote content-type="editor-comment"><p>2. The authors should define different cell stainings better (e.g. what type of cells do Tbr-Sox2- cells represent).</p></disp-quote><p>We have added additional descriptors to clarify this in the figure legends and in the results.</p><disp-quote content-type="editor-comment"><p>3. How do the authors explain that there seem to be significantly more Sox2<sup>+</sup>/EdU+ cells in Figure 4D, but not Sox2<sup>+</sup> Tbr2- EdU+ cells in Figure 4 – figure 3B?</p></disp-quote><p>We specifically counted EdU+<italic>Sox2</italic><sup>+</sup>Tbr2- and EdU+<italic>Sox2</italic><sup>+</sup>Tbr2+ cells to try to tease apart possible differences in cell cycle exit between RGCs and immature IPs (<italic>Sox2</italic><sup>+</sup>Tbr2+) cells. Although we didn’t see a significant increase in EdU+<italic>Sox2</italic><sup>+</sup>Tbr2- subtypes, when we combined all <italic>Sox2</italic><sup>+</sup> cells (<italic>Sox2</italic><sup>+</sup>Tbr2- and <italic>Sox2</italic><sup>+</sup>Tbr2+), we saw a significant increase. However, we appreciate including all of these different sub-types is confusing, especially as these trends were not significant. In order to be consistent with the quantifications of progenitors in Figure 3, we have removed the analyses of these subtypes (old Figure 4—figure supplement 1B,C).</p><disp-quote content-type="editor-comment"><p>4. In Figure 5D, what does the white bar represent? Only 1 division or no division at all? This should be clarified in the legend.</p></disp-quote><p>We apologize for this oversight and have updated the figure and figure legend to clarify. The white bar represents cells that only divided once. We did not analyze non-dividing cells.</p><disp-quote content-type="editor-comment"><p>5. The reference RK, C.Y. et al., is not written correctly, the first author should be Yuen, R.K.C.</p></disp-quote><p>We have fixed this reference.</p><disp-quote content-type="editor-comment"><p>6. The authors comment on the spectrum of nonsense mutations that may be either LOF or hypomorphic. It is unclear to me what the authors mean by this, could they clarify this statement?</p></disp-quote><p>We meant to suggest that there may be a spectrum of mutations annotated as nonsense: those that act as a pure LoF (ie: an N-terminal nonsense mutation that undergoes NMD) versus a mutation that is hypomorphic (ie: a C-terminal mutation that escapes NMD and might have some functional protein activity). We have modified the wording on these to clarify (p. 18).</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>Major questions:</p><p>1) de novo DDX3X human mutations are associated with intellectual disability and over 80% of patients show abnormal corpus callosum. Do heterozygous Ddx3x cKO female mice and/or cKO males display comparable corpus callosum and learning/behavior phenotypes?</p></disp-quote><p>This is a fascinating question. We examined the corpus callosum using CUBIC along with LSL-Tomato reporters driven by <italic>Emx1</italic>-Cre in E18.5 in cHet females and cKO males (please see <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>). We did not observe a striking defect. However, <italic>DDX3X</italic> patients have thin posterior corpus callosum and this likely necessitates analysis at later stages. Moreover, there may be non-cell autonomous contributions (outside the <italic>Emx1</italic> lineage). Thus, we feel this analysis is best done in future studies at later stages and using a germline model such as <italic>Sox2</italic>-Cre. Of note, a germline mouse model of <italic>Ddx3x</italic> cHET did not specifically describe callosal defects [2]. However, this study did report extensive behavioral defects of females. Of further relevance, the callosal defects in patients are most severe in individuals harboring missense mutations, so measuring the corpus callosum in missense models will be especially fruitful.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Representative 100um optical sagittal sections (50um on either side of the midsagittal plane) of brains of noted genotype generated using Imaris software.</title><p>Scale bar = 300mm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78203-sa2-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>2) The authors suggested that Ddx3y loss of function phenocopies Ddx3x lof with the CRISPR IUE assay. This point could be further strengthened with another control – Ddx3y sgRNA IUE in female embryos, which probably had been collected in parallel with the samples shown in Figure 2D. In addition, given that ~15% of cells underwent apoptosis in homozygous cKO females, does Ddx3y sgRNA IUE in cKO males induce similar effects?</p></disp-quote><p>For these experiments we focused on collection and analysis of males, after confirming quantitatively that the gRNAs were specific to <italic>Ddx3y</italic> (Figure 2C). Please see <xref ref-type="fig" rid="sa2fig2">Author response image 2</xref> for some images of female embryos treated with <italic>Ddx3y</italic> sgRNAs. Our preliminary analysis of two IUE’d brains suggests there is no striking phenotype. Because our n’s are low, we did not quantify this.</p><fig id="sa2fig2" position="float"><label>Author response image 2.</label><caption><title>Representative images of female cortices electroporated with <italic>Ddx3y</italic> gRNA.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-78203-sa2-fig2-v1.tif"/></fig><p>We tried the suggested experiment, to IUE <italic>Ddx3y</italic> sgRNAs into cKO males, but encountered technical difficulties with obtaining good IUEs, perhaps because of delayed cell cycle, and other neurogenesis defects already present in this genotype.</p><disp-quote content-type="editor-comment"><p>3) The authors described Figure 4G as E14.5 but the brain sections appear much thinner (than Figure 4A for example) and more proliferative than typical E14.5 tissues.</p></disp-quote><p>Figures 4A and 4G were brains from separate experiments and litters. For experiments in 4G we evaluated sections which were slightly more medial, which explains why these look “younger”. We confirmed these are indeed E14.5. We have clarified this in the figure legend. In previous cell cycle analyses by our lab at E13.5 the Tc is much lower, at15 hours. While these sections were more medial, our live imaging of the whole dorsal telencephalon supports the conclusion that cell cycle is longer in Ddx3x deficient progenitors (Figure 5C).</p><disp-quote content-type="editor-comment"><p>4) Figure 6D used adjusted p-value &lt;0.1 as the threshold, which is not a typical practice. We recommend filtering target genes with a more stringent standard.</p></disp-quote><p>Please see our response #3 to Essential Revisions.</p><disp-quote content-type="editor-comment"><p>5) For Ddx3x dependent gene translation, are these Ribo-Seq targets directly regulated by Ddx3x? Are they overall enriched in certain biological functions?</p></disp-quote><p>This is a fascinating question and thank you for the suggestion. We have thus performed DDX3X RNA immunoprecipitation for the same candidates we validated in Figure 6 (<italic>Setd3</italic>, <italic>Rcor2</italic>, and <italic>Topbp1</italic>). These new data show these 3 key translational targets are bona fide targets of DDX3X. These data are now included in Figure 6—figure supplement 2D. With so few genes we did not see a strong bias in GO analysis, only a few pathways are weakly enriched (nucleus, RNA binding) and thus, we did not include this analysis. However, we do note in the discussion that several targets are epigenetic regulators.</p><p>References</p><p>1. Chen, C.-Y., et al., <italic>Targeted inactivation of murine Ddx3x: essential roles of Ddx3xin placentation and embryogenesis.</italic> Human molecular genetics, 2016: p. ddw143-18.</p><p>2. Boitnott, A., et al., <italic>Developmental and Behavioral Phenotypes in a Mouse Model of DDX3X Syndrome.</italic> Biol Psychiatry, 2021. 90(11): p. 742-755.</p></body></sub-article></article>